var title_f7_26_7584="Thoracic aortic dissection on computed tomography";
var content_f7_26_7584=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F81919&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F81919&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Thoracic aortic dissection on computed tomography",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Transverse plane through ascending (AA) and descending (DA) thoracic aorta showing the intimal flap (arrows) and both lumens of a type A aortic dissection. One cannot distinguish between the true and false lumens based on this view alone.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Vassilios Raptopoulos, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_26_7584=[""].join("\n");
var outline_f7_26_7584=null;
var title_f7_26_7585="CF atelectasis1";
var content_f7_26_7585=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F53555&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F53555&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Right upper lobe atelectasis in a newborn with cystic fibrosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 351px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest radiograph of a newborn male with cystic fibrosis and&nbsp;right upper lobe&nbsp;atelectasis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan D Finder, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_26_7585=[""].join("\n");
var outline_f7_26_7585=null;
var title_f7_26_7586="Erythematous skin lesion of mucormycosis";
var content_f7_26_7586=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F65712&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F65712&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Erythematous skin lesion of mucormycosis with necrotic component",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 372px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythematous skin lesion with a necrotic component, caused by mucormycosis in a liver transplant recipient.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol Kauffman, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_26_7586=[""].join("\n");
var outline_f7_26_7586=null;
var title_f7_26_7587="Internal jugular cannulation techniques";
var content_f7_26_7587=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F55705&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F55705&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Internal jugular vein cannulation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 301px; height: 530px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     A: anterior route; B: central route; C: posterior route.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_26_7587=[""].join("\n");
var outline_f7_26_7587=null;
var title_f7_26_7588="Betaine: Patient drug information";
var content_f7_26_7588=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Betaine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/49/41747?source=see_link\">",
"     see \"Betaine: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23459?source=see_link\">",
"     see \"Betaine: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F140590\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Cystadane&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F140591\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Cystadane&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10014688\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691897",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat homocystinuria.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10014687\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701617",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to betaine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10014692\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10014693\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10014695\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10014690\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696181",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use only the scoop that comes with the powder to measure powder.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695458",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Mix with 4 to 6 ounces of water, milk, or fruit juice.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink it right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2820846",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may also mix it with food.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10014691\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10014696\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699150",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use if the powder does not melt fully or solution is colored.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10014697\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11588 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-180.241.123.62-8D972B75FE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_26_7588=[""].join("\n");
var outline_f7_26_7588=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140590\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140591\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014688\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014687\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014692\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014693\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014695\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014690\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014691\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014696\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014697\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?40/49/41747?source=related_link\">",
"      Betaine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23459?source=related_link\">",
"      Betaine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_26_7589="Ixabepilone: Patient drug information";
var content_f7_26_7589=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Ixabepilone: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/11/10423?source=see_link\">",
"     see \"Ixabepilone: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F5376467\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Ixempra&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10023997\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug with capecitabine if you have very bad liver disease. Unsafe effects may happen. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4090502",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may irritate the vein. It may burn the skin if the drug leaks from the vein when it is given. Tell your nurse if you have any redness, burning, pain, swelling, or leaking of fluid where the drug is going into your body.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10023999\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691765",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat breast cancer.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2836132",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat endometrial cancer.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10023998\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702342",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to ixabepilone, Cremophor&reg; EL, polyoxyethylated castor oil, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701367",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a low platelet count or a low white blood cell count.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703829",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have very bad liver disease and are taking capecitabine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10024003\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697172",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any nerve problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696900",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take St John's wort with this drug. This drug may not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10024004\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698221",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Low white blood cell count or low platelet count. This drug may need to be stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698114",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hair loss. Hair most often grows back when this drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698243",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Mouth irritation or sores. Using a soft toothbrush or cotton swabs and rinsing the mouth may help. Do not use mouth rinses that have alcohol in them.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698984",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not hungry.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698249",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Muscle pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698288",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Numbness and tingling.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10024006\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure or a fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10024001\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694653",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Diphenhydramine and other drugs may be given before this drug to lower itching.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10024008\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11977 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-14.112.150.12-587BC34546-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_26_7589=[""].join("\n");
var outline_f7_26_7589=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5376467\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023997\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023999\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023998\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024003\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024004\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024006\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024001\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024008\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?10/11/10423?source=related_link\">",
"      Ixabepilone: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_26_7590="Chagas cardiomyopathy with late gadolinium enhancement";
var content_f7_26_7590=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F77078&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F77078&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 567px\">",
"   <div class=\"ttl\">",
"    Chagas cardiomyopathy with late gadolinium enhancement",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 547px; height: 289px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cardiovascular magnetic resonance&nbsp;study of a 52-year-old man with Chagas cardiomyopathy&nbsp;who recovered from&nbsp;sudden cardiac arrest&nbsp;due to ventricular fibrillation. Arrows&nbsp;indicate late gadolinium enhancement consistent with focal&nbsp;fibrosis&nbsp;of the left ventricle.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_26_7590=[""].join("\n");
var outline_f7_26_7590=null;
var title_f7_26_7591="Overview of hepatitis A virus infection in adults";
var content_f7_26_7591=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of hepatitis A virus infection in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/26/7591/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/26/7591/contributors\">",
"     Catherine P Cheney, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/26/7591/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/26/7591/contributors\">",
"     Martin S Hirsch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/26/7591/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/26/7591/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?7/26/7591/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatitis A virus (HAV) causes an acute hepatitis associated with significant morbidity and occasional mortality. Terms such as epidemic jaundice, acute catarrhal jaundice, and campaign jaundice have been used to describe this infection.",
"   </p>",
"   <p>",
"    Two distinct clinical forms of hepatitis were recognized in 1947 and designated hepatitis A and hepatitis B [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/1\">",
"     1",
"    </a>",
"    ]; the virus that causes hepatitis A (HAV) was identified in 1973 [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/2\">",
"     2",
"    </a>",
"    ]. Extensive research has culminated in the development of vaccines that can prevent acute hepatitis A. In addition, although most patients recover spontaneously, liver transplantation has revolutionized the treatment of fulminant hepatic failure resulting from infection.",
"   </p>",
"   <p>",
"    The epidemiology, major clinical manifestations, diagnosis, and treatment of HAV infection will be reviewed here. Atypical manifestations, such as cholestatic hepatitis, relapsing hepatitis, and extrahepatic manifestations, are discussed separately, as are issues related to hepatitis A vaccination. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/13/32980?source=see_link\">",
"     \"Atypical manifestations of hepatitis A virus infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/38/1641?source=see_link\">",
"     \"Hepatitis A virus vaccination and postexposure prophylaxis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENOMIC ORGANIZATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;HAV is a 27 nm, nonenveloped, icosahedral, positive-stranded RNA virus classified in the Heparnavirus genus of the Picornaviridae family. The hepatitis A viral genome is comprised of 7474 nucleotides divided into three regions: a 5' untranslated region (742 nucleotides); a single long open reading frame that encodes a 2227 amino acid polypeptide (6681 nucleotides); and a 3' noncoding region (63 nucleotides). The polypeptide encoded by the open reading frame is cotranslationally processed by a viral protease, resulting in four structural and seven nonstructural proteins (",
"    <a class=\"graphic graphic_figure graphicRef72541 \" href=\"UTD.htm?5/61/6110\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Four distinct genotypes of HAV have been identified in humans, although they do not appear to have important biological differences [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/3\">",
"     3",
"    </a>",
"    ]. All four genotypes belong to a single serotype.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;HAV infection occurs worldwide (",
"    <a class=\"graphic graphic_figure graphicRef69392 \" href=\"UTD.htm?8/14/8424\">",
"     figure 2",
"    </a>",
"    ). In the United States, the incidence has declined substantially since vaccination was recommended for persons at increased risk (in 1996), children living in states with the highest incidence of HAV (in 1999) and for all United States-born infants (in 2006) (",
"    <a class=\"graphic graphic_figure graphicRef60763 \" href=\"UTD.htm?13/19/13626\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Acute hepatitis A incidence has declined by 92 percent between 1995 and 2007, from 12 to 1 case per 100,000 [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. Among six United States sites conducting hepatitis surveillance during 2005 to 2007, 1156 cases were reported [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/8\">",
"     8",
"    </a>",
"    ]. The decline was most pronounced in states that routinely vaccinate children compared with other states. As a result, the proportion of cases among adults has increased.",
"   </p>",
"   <p>",
"    HAV is spread via the fecal-oral route, and is more prevalent in low socioeconomic areas where a lack of adequate sanitation and poor hygienic practices facilitate spread of the infection (",
"    <a class=\"graphic graphic_table graphicRef80824 \" href=\"UTD.htm?10/3/10299\">",
"     table 1",
"    </a>",
"    ). The most common reported risk factor in the United States is international travel (up to 50 percent of cases), mainly to Mexico and",
"    <span class=\"nowrap\">",
"     Central/South",
"    </span>",
"    America [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/6,8\">",
"     6,8",
"    </a>",
"    ]. Other risk factors include sexual and household contact with another person with hepatitis A (reported in about 10 percent of cases), homosexual activity in men (about 9 percent), food- or waterborne outbreaks (about 7 percent), child or employee in a daycare center (about 4 percent), and injection drug use (about 3 percent). Maternal-fetal transmission has not been reported.",
"   </p>",
"   <p>",
"    Community outbreaks due to contaminated water or food have also been described. In one such report, HAV RNA could be detected in well water six months after the initial contamination [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/9\">",
"     9",
"    </a>",
"    ]. HAV can be acquired from contaminated food, including shellfish and vegetables. Several outbreaks related to consumption of contaminated green onions have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. In addition, a number of international outbreaks have demonstrated that vaccination of individuals in developed countries is increasingly being counterbalanced by importation of foods from endemic areas of the world [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/11-13\">",
"     11-13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hepatitis A can occur sporadically or in an epidemic form. However, some sporadic occurrences may be unrecognized cases from geographically distant regional outbreaks. In one report, for example, 213 cases of hepatitis A were detected from 23 schools in Michigan, and 29 cases from 13 schools in Maine; all were related to contaminated frozen strawberries [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/14\">",
"     14",
"    </a>",
"    ]. The genetic sequence of the virus was identical to five cases reported in Wisconsin, seven in Arizona, and two in Louisiana. These patients would have been considered sporadic cases had genetic sequencing of the virus and careful epidemiologic tracking not been performed. HAV is often transmitted within networks of persons with similar risk factors suggesting that some sporadic cases may be explainable [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/15\">",
"     15",
"    </a>",
"    ]. Nevertheless, hepatitis A occurs sporadically in approximately 40 percent of cases in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Population immunity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The global epidemiology of the disease is changing, largely due to the improvement of living conditions in underdeveloped countries. As a result, fewer children are infected, leading to a larger population of adults who lack protective antibodies against HAV.",
"   </p>",
"   <p>",
"    The decrease in population immunity in endemic countries has resulted in an increasingly large group of adults who are at risk for outbreaks of infection. In one report in 1988, approximately 290,000 people in Shanghai, China developed acute hepatitis A infection that was traced to a species of clam sold in large quantities in Shanghai markets (",
"    <em>",
"     Anadara subcrenata",
"    </em>",
"    lusche) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PATHOGENESIS OF HEPATIC INJURY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injury to the liver is secondary to the host's immune response. Replication of HAV occurs exclusively within the cytoplasm of the hepatocyte, where the virus causes a noncytopathic infection. Hepatocellular damage and destruction of infected hepatocytes is mediated by HLA-restricted, HAV-specific CD8+ T lymphocytes and natural killer cells [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/18-20\">",
"     18-20",
"    </a>",
"    ]. Interferon gamma appears to have a central role in promoting clearance of infected hepatocytes [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/18\">",
"     18",
"    </a>",
"    ]. An excessive host response (observable clinically by a marked degree of reduction of HAV RNA during acute infection) is associated with severe hepatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CLINICAL EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;HAV infection usually results in an acute, self-limited illness and only rarely leads to fulminant hepatic failure [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/22\">",
"     22",
"    </a>",
"    ]. Fulminant hepatic failure occurs more commonly in patients with underlying liver disease, particularly chronic hepatitis C virus infection. This was illustrated in a study of 163 patients with chronic hepatitis B and 432 patients with chronic hepatitis C followed prospectively for seven years [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/23\">",
"     23",
"    </a>",
"    ]. Hepatitis A superinfection occurred in 27 patients. An uncomplicated course occurred in 9 of the 10 patients with hepatitis B who acquired hepatitis A; one patient who also had preexisting cirrhosis developed marked cholestasis. In comparison, fulminant hepatic failure developed in 7 of the 17 patients with HCV who acquired hepatitis A; six of these patients died.",
"   </p>",
"   <p>",
"    The manifestations also vary with age. HAV infection is usually silent or subclinical in children. In contrast, infection in adults can vary in severity from a mild flu-like illness to fulminant hepatitis.",
"   </p>",
"   <p>",
"    The incubation period averages 30 days (range 15 to 49 days), after which the illness begins with the abrupt onset of prodromal symptoms including, fatigue, malaise, nausea, vomiting, anorexia, fever, and right upper quadrant pain [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/24\">",
"     24",
"    </a>",
"    ]. Within a few days to one week, patients note dark urine, acholic stool (light-colored stools lacking bilirubin pigment), jaundice, and pruritus. The prodromal symptoms usually diminish when jaundice appears; jaundice typically peaks within two weeks (",
"    <a class=\"graphic graphic_figure graphicRef57931 \" href=\"UTD.htm?16/1/16414\">",
"     figure 4",
"    </a>",
"    ). HAV is rarely associated with a relapsing or cholestatic clinical illness, and may serve as a trigger for autoimmune hepatitis in genetically susceptible individuals. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/13/32980?source=see_link\">",
"     \"Atypical manifestations of hepatitis A virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The two most common physical findings are jaundice and hepatomegaly, which occur in 70 and 80 percent of symptomatic patients, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/25\">",
"     25",
"    </a>",
"    ]. Less common findings include splenomegaly, cervical lymphadenopathy, evanescent rash, arthritis, and, rarely, a leukocytoclastic vasculitis.",
"   </p>",
"   <p>",
"    A variety of extrahepatic manifestations have been associated with acute HAV infection including vasculitis, arthritis, optic neuritis, transverse myelitis, thrombocytopenia, aplastic anemia, and red cell aplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/26\">",
"     26",
"    </a>",
"    ]. These conditions are more likely in patients who have protracted illness. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/13/32980?source=see_link\">",
"     \"Atypical manifestations of hepatitis A virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory abnormalities may include marked elevations of serum aminotransferases (usually &gt;1000",
"    <span class=\"nowrap\">",
"     IU/dL),",
"    </span>",
"    serum total and direct bilirubin, and alkaline phosphatase [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/25\">",
"     25",
"    </a>",
"    ]. The serum alanine aminotransferase (ALT) is commonly higher than the serum aspartate aminotransferase (AST). The serum aminotransferase elevations precede the bilirubin elevation, with the peak bilirubin concentration occurring after the peak aminotransferase elevations. Serum bilirubin levels above 10",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    are common. Other laboratory abnormalities include nonspecific elevations of acute phase reactants, elevated erythrocyte sedimentation rate, and increased immunoglobulins.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of acute HAV infection is made by the detection of anti-HAV antibodies in a patient with the typical clinical presentation. Serum IgM anti-HAV is the gold standard for the detection of acute illness. The presence of serum IgM anti-HAV antibodies in adults without clinical features of viral hepatitis does not necessarily indicate acute infection. Such patients may have previous HAV infection with prolonged presence of IgM anti-HAV, a false-positive result, or asymptomatic infection (which is much more common in children less than six compared with older children and adults) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Anti-HAV is positive at the onset of symptoms, peaks during the acute or early convalescent phase of the disease, and remains positive for approximately four to six months (",
"    <a class=\"graphic graphic_figure graphicRef57931 \" href=\"UTD.htm?16/1/16414\">",
"     figure 4",
"    </a>",
"    ). The serologic detection of antibodies is simpler, easier, and less expensive than other techniques, such as HAV detection in stool and body fluids by electron microscopy and HAV RNA detection in stool, body fluids, serum, and liver tissue. IgG anti-HAV appears early in the convalescent phase of the disease, and remains detectable for decades.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     TREATMENT AND PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because the disease is usually self-limited, the treatment is supportive. Occasional patients require hospitalization (20 percent in the large outbreak described above [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/11\">",
"     11",
"    </a>",
"    ]). Patients who develop fulminant infection require aggressive supportive therapy, and should be transferred to a center capable of performing liver transplantation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/17/2330?source=see_link\">",
"     \"Acute liver failure in adults: Etiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Approximately 85 percent of HAV-infected individuals have full clinical and biochemical recovery within three months, and nearly all have complete recovery by six months [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/28\">",
"     28",
"    </a>",
"    ]. Serum aminotransferase concentrations decrease more rapidly than the serum bilirubin; the latter normalizes in more than 85 percent of individuals by three months.",
"   </p>",
"   <p>",
"    Fatalities due to hepatitis A are more common with advancing age and in patients with chronic hepatitis C [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/23,29\">",
"     23,29",
"    </a>",
"    ]. Reported case fatality rates are 0.1 percent in infants and children, 0.4 percent between the ages of 15 and 39, and 1.1 percent in those over age 40 [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Issues related to HAV during pregnancy are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/24/14726?source=see_link\">",
"     \"Intercurrent hepatobiliary disease during pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatitis A is transmitted predominantly by the fecal-oral route. The incubation period is 2 to 6 weeks; infected individuals are contagious during the incubation period and remain so for about a week after jaundice appears [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prevention can be aided by adherence to sanitary practices such as handwashing, heating foods appropriately, and avoidance of water and foods from endemic areas. Handwashing is highly effective in preventing the transmission of the virus since HAV may survive for up to four hours on the fingertips [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/32\">",
"     32",
"    </a>",
"    ]. Chlorination and certain disinfecting solutions (household bleach 1:100 dilution) are sufficient to inactivate the virus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Preexposure prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Passive immunization with intramuscular polyclonal serum immune globulin prior to exposure has been available since the 1940s and can decrease the incidence of HAV infection by more than 90 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/33-35\">",
"     33-35",
"    </a>",
"    ]. Passive immunity lasts for up to six months depending upon the dose of immunoglobulin used, but is effective only if administered within",
"    <strong>",
"     two weeks",
"    </strong>",
"    of exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7591/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, several factors preclude widespread use of immunoglobulin prophylaxis. It is expensive, causes pain at the injection site, requires readministration every three to six months, and risks transmission of infectious agents due to the pooled, blood-derived source of the immunoglobulin preparation. As a result, immunoglobulin preexposure prophylaxis should be reserved for nonimmune individuals who are at risk for exposure hepatitis to A or who are allergic to the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/30/44518?source=see_link\">",
"     hepatitis A vaccine",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/21/2394?source=see_link\">",
"     \"Immunizations for travel\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Postexposure prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The issue of postexposure with intramuscular immune serum globulin with or without HAV vaccination is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/38/1641?source=see_link\">",
"     \"Hepatitis A virus vaccination and postexposure prophylaxis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Vaccination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several highly effective and safe vaccines are available for viral hepatitis A. Recommendations for vaccination are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/38/1641?source=see_link\">",
"     \"Hepatitis A virus vaccination and postexposure prophylaxis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?40/46/41698?source=see_link\">",
"       \"Patient information: Hepatitis A (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?21/61/22483?source=see_link\">",
"       \"Patient information: Hepatitis A (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7717987\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hepatitis A virus (HAV) causes an acute hepatitis; infection occurs worldwide (",
"      <a class=\"graphic graphic_figure graphicRef69392 \" href=\"UTD.htm?8/14/8424\">",
"       figure 2",
"      </a>",
"      ). In the United States the incidence has declined substantially since vaccination was recommended for persons at increased risk; in 2007 the incidence was 1 case per 100,000 (",
"      <a class=\"graphic graphic_figure graphicRef60763 \" href=\"UTD.htm?13/19/13626\">",
"       figure 3",
"      </a>",
"      ). HAV is transmitted via the fecal-oral route, and is more prevalent in low socioeconomic areas where a lack of adequate sanitation and poor hygienic practices facilitate spread of the infection (",
"      <a class=\"graphic graphic_table graphicRef80824 \" href=\"UTD.htm?10/3/10299\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      HAV infection usually results in an acute, self-limited illness and only rarely leads to fulminant hepatic failure. Fulminant hepatic failure occurs more commonly in patients with underlying liver disease. HAV infection is frequently subclinical in children; in adults the severity of infection can vary from a mild flu-like illness to fulminant hepatitis. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Clinical evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The incubation period averages 30 days (range 15 to 49 days), after which the illness begins with the abrupt onset of prodromal symptoms including, fatigue, malaise, nausea, vomiting, anorexia, fever, and right upper quadrant pain. Within a few days to one week, patients note dark urine, acholic stool (light-colored stools lacking bilirubin pigment), jaundice, and pruritus. The prodromal symptoms usually diminish when jaundice appears. The most common physical findings are jaundice and hepatomegaly. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Clinical evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laboratory abnormalities may include marked elevations of serum aminotransferases (usually &gt;1000",
"      <span class=\"nowrap\">",
"       IU/dL),",
"      </span>",
"      serum total and direct bilirubin, and alkaline phosphatase. The diagnosis of acute HAV infection is made by the detection of serum IgM anti-HAV antibodies in a patient with the typical clinical presentation. Anti-HAV is positive at the onset of symptoms, peaks during the acute or early convalescent phase of the disease, and remains positive for approximately four to six months (",
"      <a class=\"graphic graphic_figure graphicRef57931 \" href=\"UTD.htm?16/1/16414\">",
"       figure 4",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Laboratory findings'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment consists of supportive care. Approximately 85 percent of HAV-infected individuals have full clinical and biochemical recovery within three months, and nearly all have complete recovery by six months. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Treatment and prognosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prevention can be aided by adherence to sanitary practices such as handwashing, heating foods appropriately, and avoidance of water and foods from endemic areas. Vaccination is an important prevention tool. Passive immunization with intramuscular polyclonal serum immune globulin as preexposure or postexposure prophylaxis is also available; its use is discussed separately. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Prevention'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/21/2394?source=see_link&amp;anchor=H11#H11\">",
"       \"Immunizations for travel\", section on 'Hepatitis A vaccine'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/38/1641?source=see_link\">",
"       \"Hepatitis A virus vaccination and postexposure prophylaxis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/1\">",
"      MacCallum FO. Homologous serum jaundice. Lancet 1947; 2:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/2\">",
"      Feinstone SM, Kapikian AZ, Purceli RH. Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness. Science 1973; 182:1026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/3\">",
"      Lemon SM, Jansen RW, Brown EA. Genetic, antigenic and biological differences between strains of hepatitis A virus. Vaccine 1992; 10 Suppl 1:S40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/4\">",
"      Wasley A, Samandari T, Bell BP. Incidence of hepatitis A in the United States in the era of vaccination. JAMA 2005; 294:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/5\">",
"      Advisory Committee on Immunization Practices (ACIP), Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/6\">",
"      Daniels D, Grytdal S, Wasley A, Centers for Disease Control and Prevention (CDC). Surveillance for acute viral hepatitis - United States, 2007. MMWR Surveill Summ 2009; 58:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/7\">",
"      Mutsch M, Spicher VM, Gut C, Steffen R. Hepatitis A virus infections in travelers, 1988-2004. Clin Infect Dis 2006; 42:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/8\">",
"      Klevens RM, Miller JT, Iqbal K, et al. The evolving epidemiology of hepatitis a in the United States: incidence and molecular epidemiology from population-based surveillance, 2005-2007. Arch Intern Med 2010; 170:1811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/9\">",
"      De Serres G, Cromeans TL, Levesque B, et al. Molecular confirmation of hepatitis A virus from well water: epidemiology and public health implications. J Infect Dis 1999; 179:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/10\">",
"      Dentinger CM, Bower WA, Nainan OV, et al. An outbreak of hepatitis A associated with green onions. J Infect Dis 2001; 183:1273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/11\">",
"      Wheeler C, Vogt TM, Armstrong GL, et al. An outbreak of hepatitis A associated with green onions. N Engl J Med 2005; 353:890.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/12\">",
"      Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine 2010; 28:6653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/13\">",
"      Donnan EJ, Fielding JE, Gregory JE, et al. A multistate outbreak of hepatitis A associated with semidried tomatoes in Australia, 2009. Clin Infect Dis 2012; 54:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/14\">",
"      Hutin YJ, Pool V, Cramer EH, et al. A multistate, foodborne outbreak of hepatitis A. National Hepatitis A Investigation Team. N Engl J Med 1999; 340:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/15\">",
"      Nainan OV, Armstrong GL, Han XH, et al. Hepatitis a molecular epidemiology in the United States, 1996-1997: sources of infection and implications of vaccination policy. J Infect Dis 2005; 191:957.",
"     </a>",
"    </li>",
"    <li>",
"     CDC. Hepatitis surveillance report no. 56. US Department of Health and Human Services, Public Health Service, CDC; Atlanta, GA 1996.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/17\">",
"      Tang YW, Wang JX, Xu ZY, et al. A serologically confirmed, case-control study, of a large outbreak of hepatitis A in China, associated with consumption of clams. Epidemiol Infect 1991; 107:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/18\">",
"      Vallbracht A, Fleischer B, Busch FW. Hepatitis A: hepatotropism and influence on myelopoiesis. Intervirology 1993; 35:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/19\">",
"      Fleischer B, Fleischer S, Maier K, et al. Clonal analysis of infiltrating T lymphocytes in liver tissue in viral hepatitis A. Immunology 1990; 69:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/20\">",
"      Baba M, Hasegawa H, Nakayabu M, et al. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts. J Clin Lab Immunol 1993; 40:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/21\">",
"      Rezende G, Roque-Afonso AM, Samuel D, et al. Viral and clinical factors associated with the fulminant course of hepatitis A infection. Hepatology 2003; 38:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/22\">",
"      Taylor RM, Davern T, Munoz S, et al. Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomes. Hepatology 2006; 44:1589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/23\">",
"      Vento S, Garofano T, Renzini C, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 1998; 338:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/24\">",
"      Lednar WM, Lemon SM, Kirkpatrick JW, et al. Frequency of illness associated with epidemic hepatitis A virus infections in adults. Am J Epidemiol 1985; 122:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/25\">",
"      Tong MJ, el-Farra NS, Grew MI. Clinical manifestations of hepatitis A: recent experience in a community teaching hospital. J Infect Dis 1995; 171 Suppl 1:S15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/26\">",
"      Schiff ER. Atypical clinical manifestations of hepatitis A. Vaccine 1992; 10 Suppl 1:S18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/27\">",
"      Centers for Disease Control and Prevention (CDC). Positive test results for acute hepatitis A virus infection among persons with no recent history of acute hepatitis--United States, 2002-2004. MMWR Morb Mortal Wkly Rep 2005; 54:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/28\">",
"      Koff RS. Clinical manifestations and diagnosis of hepatitis A virus infection. Vaccine 1992; 10 Suppl 1:S15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/29\">",
"      Vogt TM, Wise ME, Bell BP, Finelli L. Declining hepatitis A mortality in the United States during the era of hepatitis A vaccination. J Infect Dis 2008; 197:1282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/30\">",
"      Centers for Disease Control. Hepatitis Surveillance Report 1990; 53:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/31\">",
"      Richardson M, Elliman D, Maguire H, et al. Evidence base of incubation periods, periods of infectiousness and exclusion policies for the control of communicable diseases in schools and preschools. Pediatr Infect Dis J 2001; 20:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/32\">",
"      Mbithi JN, Springthorpe VS, Boulet JR, Sattar SA. Survival of hepatitis A virus on human hands and its transfer on contact with animate and inanimate surfaces. J Clin Microbiol 1992; 30:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/33\">",
"      Stokes J, Neefe JR. The prevention and attenuation of infectious hepatitis by gamma globulin: Preliminary note. JAMA 1945; 127:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/34\">",
"      Winokur PL, Stapleton JT. Immunoglobulin prophylaxis for hepatitis A. Clin Infect Dis 1992; 14:580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/35\">",
"      Conrad ME, Lemon SM. Prevention of endemic icteric viral hepatitis by administration of immune serum gamma globulin. J Infect Dis 1987; 156:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7591/abstract/36\">",
"      Stapleton JT. Passive immunization against hepatitis A. Vaccine 1992; 10 Suppl 1:S45.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2692 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-183.166.191.243-37B631BF3D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_26_7591=[""].join("\n");
var outline_f7_26_7591=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H7717987\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENOMIC ORGANIZATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Population immunity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PATHOGENESIS OF HEPATIC INJURY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CLINICAL EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      TREATMENT AND PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Preexposure prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Postexposure prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Vaccination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7717987\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/2692\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2692|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?5/61/6110\" title=\"figure 1\">",
"      Translation HAV genome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/14/8424\" title=\"figure 2\">",
"      Geography hepatitis A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?13/19/13626\" title=\"figure 3\">",
"      Decline HAV incidence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/1/16414\" title=\"figure 4\">",
"      Clinical course HAV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2692|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?10/3/10299\" title=\"table 1\">",
"      Modes transmission hepatitis A",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/17/2330?source=related_link\">",
"      Acute liver failure in adults: Etiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/13/32980?source=related_link\">",
"      Atypical manifestations of hepatitis A virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/38/1641?source=related_link\">",
"      Hepatitis A virus vaccination and postexposure prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/21/2394?source=related_link\">",
"      Immunizations for travel",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/24/14726?source=related_link\">",
"      Intercurrent hepatobiliary disease during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/61/22483?source=related_link\">",
"      Patient information: Hepatitis A (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?40/46/41698?source=related_link\">",
"      Patient information: Hepatitis A (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_26_7592="Endomyocardial biopsy";
var content_f7_26_7592=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Endomyocardial biopsy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/26/7592/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/26/7592/contributors\">",
"     Leslie T Cooper, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/26/7592/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/26/7592/contributors\">",
"     William J McKenna, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/26/7592/contributors\">",
"     Sharon A Hunt, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/26/7592/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/26/7592/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?7/26/7592/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Interest in the use of endomyocardial biopsy (EMB) as a diagnostic tool for patients who present with abnormal systolic or diastolic function has grown as the technique has been refined and perfected. The first transvenous EMB forcep, the Konno-Sakakibara bioptome, was developed in Japan in 1962 [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/1\">",
"     1",
"    </a>",
"    ]. A modified bioptome, the Caves-Schultz-Stanford bioptome, was developed in 1972, and versions of this device are still widely used [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/2\">",
"     2",
"    </a>",
"    ]. More flexible bioptomes with smaller jaws have been associated with very low complication rates [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/3\">",
"     3",
"    </a>",
"    ]. Declines in the procedural risk of EMB and increasing evidence of its value in diagnosis and guiding therapy are extending the role for EMB at medical referral centers with necessary technical expertise.",
"   </p>",
"   <p>",
"    Monitoring for allograft rejection after cardiac transplantation is the strongest indication for EMB. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/24/28040?source=see_link\">",
"     \"Acute cardiac allograft rejection: Diagnosis\"",
"    </a>",
"    .) The role for this procedure in other disorders, such as myocarditis and idiopathic dilated cardiomyopathy (DCM), has been more controversial.",
"   </p>",
"   <p>",
"    The general role of EMB in cardiovascular disease will be reviewed here. The importance in individual diseases will be discussed in detail on the appropriate topic reviews.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TECHNIQUE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6476041\">",
"    <span class=\"h2\">",
"     Access and imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;EMB was initially performed via the internal jugular vein and the right internal jugular vein remains the most common access site in the United States. However, the advent of long, flexible bioptomes permits a femoral venous approach with equal efficacy.",
"   </p>",
"   <p>",
"    EMB is usually performed with fluoroscopic guidance. Although fluoroscopy is generally preferred, echocardiography has also been used for guidance, primarily for biopsy of intracardiac masses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28739986\">",
"    <span class=\"h2\">",
"     Right or left ventricle",
"    </span>",
"    &nbsp;&mdash;&nbsp;EMB specimens are usually obtained from the right ventricle (RV).",
"   </p>",
"   <p>",
"    Left ventricular (LV) biopsy is rarely performed but can be obtained via an arterial approach. One indication for LV biopsy is suspected cardiac sarcoidosis in which regional involvement of the LV may be more common than that of the RV septum [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/19/17722?source=see_link\">",
"     \"Cardiac sarcoidosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A two-center study found that biventricular biopsy provided an incremental diagnostic yield over RV biopsy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/5\">",
"     5",
"    </a>",
"    ]. 755 patients with suspected myocarditis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    nonischemic cardiomyopathy underwent LV, RV, or biventricular EMB. Diagnostic EMB results were achieved more frequently in those undergoing biventricular EMB (79.3 percent) compared to those undergoing univentricular EMB (67.3 percent). In patients undergoing biventricular EMB, myocarditis was diagnosed by LV EMB in 18.7 percent, by RV EMB in 7.9 percent, and in both ventricles in 73.4 percent. Biopsy in the region of late gadolinium enhancement on cardiovascular magnetic resonance imaging did not increase the yield of diagnosis. Complication rates were similar for LV and RV biopsy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Sampling and analysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;We agree with the following recommendations regarding EMB sampling and analysis based upon the 2007 American Heart",
"    <span class=\"nowrap\">",
"     Association/American",
"    </span>",
"    College of",
"    <span class=\"nowrap\">",
"     Cardiology/European",
"    </span>",
"    Society of Cardiology",
"    <span class=\"nowrap\">",
"     (AHA/ACC/ESC)",
"    </span>",
"    scientific statement on the role of EMB [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/6\">",
"     6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Samples should be obtained from more than one region of the right ventricular septum, and the number of samples should range from 5 to 10, depending upon the studies to be performed and size of the bioptome forceps.",
"     </li>",
"     <li>",
"      At least four to five samples should be submitted for light microscopic examination.",
"     </li>",
"     <li>",
"      Analysis by transmission electron microscopy (TEM) is recommended if anthracycline cardiotoxicity is suspected. TEM is suggested if an infiltrative disorder (eg, amyloidosis) is suspected. TEM is occasionally helpful for identifying viral myocarditis.",
"     </li>",
"     <li>",
"      Tandem mass spectroscopy is useful to identify subtypes of amyloid protein [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/7\">",
"       7",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/31/1530?source=see_link&amp;anchor=H21#H21\">",
"       \"An overview of amyloidosis\", section on 'Biopsy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      At this time, routine testing for viral genomes in EMB specimens is not recommended outside of referral centers with extensive experience in viral genome analysis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6475099\">",
"    <span class=\"h2\">",
"     Considerations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since evidence of benefit of EMB is limited to specific clinical scenarios, routine EMB is",
"    <strong>",
"     not",
"    </strong>",
"    recommended in patients with new-onset HF. The 2006",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    chronic HF guidelines (with 2009 update), the 2010 Heart Failure Society of America practice guidelines, and the 2012 European Society of Cardiology heart failure guidelines note that EMB should not be performed in the routine evaluation of patients with HF [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/8-10\">",
"     8-10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Indications for EMB are predicated upon two major considerations. The first is the anticipated yield of the procedure, given the presumed prebiopsy probability of a given disorder. The second major consideration is the perceived availability of effective therapy for the diagnosis that is obtained. EMB is recommended in clinical scenarios in which the unique prognostic and diagnostic value of the information gained is felt to outweigh the procedural risks.",
"   </p>",
"   <p>",
"    The diagnostic yield of a clinical evaluation that included EMB using exclusively histological criteria (Dallas criteria) was retrospectively evaluated in a series of 1230 patients with an initially unexplained cardiomyopathy in which the following etiologies were noted [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/11\">",
"     11",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Idiopathic &mdash; 50 percent",
"     </li>",
"     <li>",
"      Myocarditis &mdash; 9 percent",
"     </li>",
"     <li>",
"      Ischemic heart disease &mdash; 7 percent",
"     </li>",
"     <li>",
"      Infiltrative disease &mdash; 5 percent",
"     </li>",
"     <li>",
"      Peripartum cardiomyopathy &mdash; 4 percent",
"     </li>",
"     <li>",
"      Hypertension &mdash; 4 percent",
"     </li>",
"     <li>",
"      HIV infection &mdash; 4 percent",
"     </li>",
"     <li>",
"      Connective tissue disease &mdash; 3 percent",
"     </li>",
"     <li>",
"      Substance abuse &mdash; 3 percent",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/37/36440?source=see_link\">",
"       Doxorubicin",
"      </a>",
"      &mdash; 1 percent",
"     </li>",
"     <li>",
"      Other &mdash; 10 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although a clinical diagnosis was established in 50 percent, a specific histologic diagnosis from EMB (mostly myocarditis (",
"    <a class=\"graphic graphic_picture graphicRef66465 \" href=\"UTD.htm?29/58/30633\">",
"     picture 1",
"    </a>",
"    ) and infiltrative disease) was obtained in only 15 percent of patients. This relatively low rate may be due in part to sampling error.",
"   </p>",
"   <p>",
"    A limitation of the above data is that current immunohistochemical and molecular techniques of viral genome analysis, which have lead to substantially increased diagnostic yield compared to conventional histopathological evaluation (Dallas criteria), were not included. Thus, the diagnostic and prognostic value of EMB was substantially underestimated [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/12-14\">",
"     12-14",
"    </a>",
"    ]. Cardiovascular magnetic resonance (CMR) or endocardial voltage mapping may further increase the yield of EMB by identifying regions with inflammation for sampling in specific disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. However, limited data are available on the efficacy of therapy guided by immunohistochemical and molecular EMB analysis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/14,17\">",
"     14,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In summary, the data suggest that the yield of therapeutically relevant information provided by EMB using histological criteria (Dallas criteria) is low in the general heart failure population. Additional techniques such as immunohistochemistry and viral genome analysis can augment the diagnostic value of EMB but limited data are available on therapy guided by such analysis. Therefore, patients with HF or cardiomyopathy should generally undergo a comprehensive evaluation, with EMB limited to those with specific indications [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/28/39369?source=see_link\">",
"     \"Evaluation of the patient with heart failure or cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The main value of EMB is in the diagnosis of certain uncommon myocardial disorders, such as giant cell myocarditis, that have unique prognoses and treatment and cannot be diagnosed by less invasive tests. Other special situations where EMB may provide unique information include disorders associated with hypereosinophilia, sarcoidosis, certain restrictive cardiomyopathies, and other types of myocarditis.",
"   </p>",
"   <p>",
"    Given the limited available evidence, recommendations in the 2007",
"    <span class=\"nowrap\">",
"     AHA/ACC/ESC",
"    </span>",
"    scientific statement regarding the use of EMB were based mainly on expert opinion [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/6\">",
"     6",
"    </a>",
"    ]. The clinical scenarios below have been adopted with modifications from the 2007 statement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6475226\">",
"    <span class=\"h2\">",
"     EMB recommended",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6474546\">",
"    <span class=\"h3\">",
"     Fulminant HF",
"    </span>",
"    &nbsp;&mdash;&nbsp;EMB is recommended in patients with unexplained new-onset HF of less than two weeks&rsquo; duration associated with a normal-sized or dilated left ventricle with hemodynamic compromise [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/6,9\">",
"     6,9",
"    </a>",
"    ]. In this setting, EMB may help establish prognosis and guide therapy.",
"   </p>",
"   <p>",
"    Patients with lymphocytic myocarditis have an early fulminant course but an excellent prognosis. Giant cell myocarditis (GCM) and necrotizing eosinophilic myocarditis may also present with a fulminant course, but both have a poor prognosis. Immunosuppressive therapy has been associated with improved outcome in GCM, although data are limited. When mechanical circulatory support is anticipated, a diagnosis of GCM may lead to use of a biventricular device because of the likelihood of progressive right ventricular failure and to an early heart transplant listing. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/39/10874?source=see_link\">",
"     \"Natural history and therapy of myocarditis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Early AV block, arrhythmias or refractory HF",
"    </span>",
"    &nbsp;&mdash;&nbsp;EMB is recommended in patients with unexplained new-onset HF of two weeks to three months&rsquo; duration associated with a dilated left ventricle and new ventricular arrhythmias, Mobitz type II second-degree atrioventricular (AV) block, third-degree AV block, or failure to respond to usual care within one to two weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/6,8\">",
"     6,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The acute onset of AV block, ventricular arrhythmias, or refractory heart failure are clinical manifestations associated with giant cell myocarditis (GCM). An EMB diagnosis of GCM would suggest a poor prognosis and may prompt immunosuppressive therapy as well as planning for cardiac transplantation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/39/10874?source=see_link&amp;anchor=H9#H9\">",
"     \"Natural history and therapy of myocarditis in adults\", section on 'Giant cell myocarditis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6475344\">",
"    <span class=\"h2\">",
"     EMB suggested in selected cases",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Late AV block, arrhythmias or refractory HF",
"    </span>",
"    &nbsp;&mdash;&nbsp;EMB is suggested in selected patients with unexplained HF of more than three months&rsquo; duration associated with a dilated left ventricle and new ventricular arrhythmias, Mobitz type II second-degree block, third-degree atrioventricular block, or failure to respond to usual care within one to two weeks.",
"   </p>",
"   <p>",
"    This scenario is suggestive of cardiac sarcoidosis, giant cell myocarditis, or idiopathic granulomatous myocarditis. Although the sensitivity of EMB in cardiac sarcoidosis is low (eg, 20 percent), EMB may help distinguish sarcoidosis from GCM, which has diagnostic and therapeutic implications. However, the diagnosis of cardiac sarcoidosis can be made without EMB if clinical features are suggestive of including the presence of non-caseating granulomas elsewhere (",
"    <a class=\"graphic graphic_table graphicRef58910 \" href=\"UTD.htm?34/56/35723\">",
"     table 1",
"    </a>",
"    ) (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/19/17722?source=see_link\">",
"     \"Cardiac sarcoidosis\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Cardiac sarcoidosis and GCM have similar rates of ventricular arrhythmias and heart block but sarcoidosis is associated with a more chronic course and better prognosis. Sarcoidosis may respond to glucocorticoid therapy, whereas combination immunotherapies have been used to treat GCM. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/19/17722?source=see_link\">",
"     \"Cardiac sarcoidosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/39/10874?source=see_link&amp;anchor=H9#H9\">",
"     \"Natural history and therapy of myocarditis in adults\", section on 'Giant cell myocarditis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Support for EMB in patients with chronic (&gt;six months) dilated cardiomyopathy unresponsive to conventional therapy comes from a randomized trial of 85 patients with EMB evidence of virus-negative myocarditis (inflammation present by immunohistology and viral genomes absent by PCR) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/17\">",
"     17",
"    </a>",
"    ]. The patients were randomly assigned to a regimen of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    or to placebo. Patients receiving immunosuppressive therapy demonstrated significant improvements in left ventricular ejection fraction and NYHA functional class not observed in those receiving placebo.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     DCM with eosinophilia",
"    </span>",
"    &nbsp;&mdash;&nbsp;EMB is suggested in selected patients with unexplained HF with a dilated cardiomyopathy of any duration associated with a suspected allergic reaction in addition to eosinophilia. This scenario is suggestive of hypersensitivity myocarditis (HSM), which is associated with a wide range of presentations. However, drug hypersensitivity may manifest as HSM, giant cell myocarditis (GCM), granulomatous myocarditis, or necrotizing eosinophilic myocarditis. EMB is reasonable when drug hypersensitivity is suspected, as it may help distinguish HSM from GCM and necrotizing myocarditis, both of which are associated with poor prognosis. Early diagnosis of HSM may lead to withdrawal of offending medications and administration of high-dose glucocorticoids. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/28/22986?source=see_link\">",
"     \"Etiology and pathogenesis of myocarditis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/39/10874?source=see_link\">",
"     \"Natural history and therapy of myocarditis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Anthracycline cardiotoxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anthracycline cardiotoxicity is generally diagnosed via noninvasive monitoring. Although EMB is considered to be the most sensitive and specific method for evaluating anthracycline cardiotoxicity, it is reserved for situations in which the cause of cardiac dysfunction is uncertain, selected cases in which administration of greater than the usual upper limit of an agent is being considered, or clinical studies of toxicity of newer agents and regimens. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/46/41706?source=see_link\">",
"     \"Cardiotoxicity of anthracycline-like chemotherapy agents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Restrictive cardiomyopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;EMB is suggested in selected patients with HF associated with restrictive cardiomyopathy if other work-up is inconclusive.",
"   </p>",
"   <p>",
"    Patients with HF and evidence of restrictive cardiomyopathy should undergo evaluation to determine whether restriction or constrictive pericarditis is present. Possible causes of restrictive cardiomyopathy (such as amyloidosis or hemochromatosis) may be suggested by associated clinical features and noninvasive evaluation (including distinctive features on cardiac magnetic resonance imaging). If other evaluation is inconclusive, EMB may reveal a specific infiltrative disorder (eg, amyloidosis) or storage disease (eg, hemochromatosis) or myocardial fibrosis and myocyte hypertrophy consistent with idiopathic restrictive cardiomyopathy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/3/30777?source=see_link\">",
"     \"Definition and classification of the cardiomyopathies\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23207?source=see_link\">",
"     \"Idiopathic restrictive cardiomyopathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/12/12490?source=see_link\">",
"     \"Constrictive pericarditis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/3/29752?source=see_link\">",
"     \"Differentiating constrictive pericarditis and restrictive cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Selected cardiac tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;EMB is suggested for diagnosis of selected suspected cardiac tumors. Due to the risk of embolization, EMB should not be performed if features are suggestive of myxoma.",
"   </p>",
"   <p>",
"    Cardiac tumors are generally identified and initially characterized by noninvasive imaging (eg, echocardiography, cardiac magnetic resonance imaging [CMR], and computed tomography). Initial evaluation includes distinguishing tumor from cardiac structures, artifact, and thrombus. When the clinical features suggest that surgical resection is indicated, a definite diagnosis is generally established from examination of the operative specimen. &nbsp;",
"   </p>",
"   <p>",
"    The diagnostic yield and potential risks of EMB in this setting are not well defined because data are limited. In selected cases, EMB is suggested for diagnosis of a cardiac tumor. EMB is reasonable if the potential benefit from the procedure outweighs the potential risk with the following conditions: (1) artifact or normal variants have been excluded as potential causes for a tumor-like appearance, (2) the diagnosis cannot be established by noninvasive means (such as CMR), (3) it is unclear if surgical resection is indicated, (4) tissue diagnosis can be expected to influence the course of therapy, (4) the chances of successful EMB are believed to be reasonably high, and (5) the procedure is performed by an experienced operator. Guidance with transesophageal echocardiography when possible is advised. Since myxomas can embolize with manipulation, we recommend against EMB if the tumor has features typical of a myxoma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/32/17930?source=see_link\">",
"     \"Cardiac tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Unexplained cardiomyopathy in children",
"    </span>",
"    &nbsp;&mdash;&nbsp;EMB is suggested in selected children with fulminant or acute unexplained HF, or idiopathic DCM.",
"   </p>",
"   <p>",
"    Rarely, EMB is performed in patients with other forms of cardiomyopathy, such as arrhythmogenic right ventricular cardiomyopathy, restrictive cardiomyopathy, and hypertrophic cardiomyopathy. (See",
"    <a class=\"local\" href=\"#H5047341\">",
"     'ARVC'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    A retrospective study found that early EMB in 40 children presenting with dilated cardiomyopathy and acute heart failure identified 14 individuals with myocarditis. Ten individuals with myocarditis responded to medical therapy and could be managed without heart transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/18\">",
"     18",
"    </a>",
"    ]. Most myocarditis in children is presumed to be viral; various viruses have differing histopathologic findings and may be identified by PCR. Such identification may have prognostic value. Data are limited, so the assessment of EMB as reasonable in this setting is based upon expert opinion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/53/34647?source=see_link\">",
"     \"Clinical manifestations and diagnosis of myocarditis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5047314\">",
"    <span class=\"h3\">",
"     HCM with HF",
"    </span>",
"    &nbsp;&mdash;&nbsp;EMB is generally not needed to evaluate patients with unexplained hypertrophic cardiomyopathy. EMB is suggested in selected patients with HF with unexplained left ventricular hypertrophy when a storage disease (such as Fabry disease) or an infiltrative process (such as amyloidosis) is suspected and noninvasive evaluation is inconclusive. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/42/36522?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and evaluation of hypertrophic cardiomyopathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/45/17111?source=see_link\">",
"     \"Cardiac manifestations of Fabry disease and screening in patients with left ventricular hypertrophy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/10/23722?source=see_link\">",
"     \"Clinical manifestations and diagnosis of amyloid cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5047341\">",
"    <span class=\"h3\">",
"     ARVC",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of arrhythmogenic right ventricular cardiomyopathy is established by a multi-parametric noninvasive and invasive evaluation; occasionally, EMB is necessary. The potential role of EMB is this setting is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/22/32106?source=see_link&amp;anchor=H21#H21\">",
"     \"Clinical manifestations and diagnosis of arrhythmogenic right ventricular cardiomyopathy\", section on 'Endomyocardial biopsy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6475528\">",
"    <span class=\"h2\">",
"     EMB of unproven value",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Recent onset DCM",
"    </span>",
"    &nbsp;&mdash;&nbsp;EMB is not generally indicated in patients with unexplained new onset HF of two weeks to three months&rsquo; duration associated with a dilated cardiomyopathy (DCM), without new ventricular arrhythmias or Mobitz type II second-degree AV block, or third-degree AV block, that responds to usual care within one to two weeks.",
"   </p>",
"   <p>",
"    The utility of EMB in this setting is uncertain since many patients with this presentation improve with standard HF therapy. The prevalence of a pathologic diagnosis of lymphocytic myocarditis using exclusively the histological criteria (Dallas criteria) has varied widely (0 to 63 percent) in this setting. Of note, the risk of death or heart transplantation in lymphocytic myocarditis with two weeks or more of symptoms and lack of viral prodrome is greater than in fulminant lymphocytic myocarditis described above in Clinical scenario 1.",
"   </p>",
"   <p>",
"    EMB is not recommended for the routine evaluation of patients with recent onset DCM that is responsive to usual care. EMB in this setting is under investigation in certain specialized tertiary referral centers where immunohistochemistry and viral PCR are frequently performed to determine etiology and guide therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/12-14,17\">",
"     12-14,17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/39/10874?source=see_link&amp;anchor=H5#H5\">",
"     \"Natural history and therapy of myocarditis in adults\", section on 'Lymphocytic, presumably viral myocarditis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Dilated cardiomyopathy (DCM) has been associated with a wide range of viruses including enteroviruses, adenoviruses, parvovirus B19, cytomegalovirus, Epstein-Barr virus, human herpesvirus 6, HIV, and hepatitis C. EMB with combined histology (Dallas criteria), immunohistochemical, and molecular techniques of viral genome analysis is the gold standard to achieve etiopathogenetic diagnosis of viral versus autoreactive (virus-negative) inflammatory heart muscle disease [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/12-14,17\">",
"     12-14,17",
"    </a>",
"    ]. However, the efficacy of etiology directed therapy in this setting is uncertain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Chronic DCM",
"    </span>",
"    &nbsp;&mdash;&nbsp;EMB is not generally indicated in patients with unexplained HF of more than three months&rsquo; duration associated with a dilated cardiomyopathy (DCM), without new ventricular arrhythmias or Mobitz type II second-degree AV block, or third-degree AV block, that responds to usual care within one to two weeks.",
"   </p>",
"   <p>",
"    Limited data are available on the efficacy of treatment guided by EMB analysis in patients with chronic DCM [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/14,17\">",
"     14,17",
"    </a>",
"    ]. Some patients with symptomatic HF after six months of optimal therapy may show improvement in LV ejection fraction after immunosuppressive therapy, but more data are needed. The use of EMB to guide risk stratification and therapy in patients with chronic DCM is under investigation [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/12-14,17\">",
"     12-14,17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/39/10874?source=see_link&amp;anchor=H14#H14\">",
"     \"Natural history and therapy of myocarditis in adults\", section on 'Immunosuppressive therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Chronic DCM patients with myocardial iron overload due to hereditary or acquired hemochromatosis can be diagnosed by noninvasive evaluation including cardiac magnetic resonance imaging. When noninvasive testing is nondiagnostic, EMB can be useful. Treatment of iron overload can reverse ventricular dysfunction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/60/28617?source=see_link&amp;anchor=H14#H14\">",
"     \"Clinical manifestations of hereditary hemochromatosis\", section on 'Heart disease'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/19/35129?source=see_link\">",
"     \"Pathophysiology and diagnosis of iron overload syndromes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/32/18952?source=see_link\">",
"     \"Treatment of hereditary hemochromatosis\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Unexplained arrhythmias",
"    </span>",
"    &nbsp;&mdash;&nbsp;The utility of performing EMB in patients with unexplained arrhythmias has not been established. Some patients with unexplained arrhythmias (supraventricular or ventricular) have myocarditis and myocarditis may present as unexplained life-threatening arrhythmia or sudden cardiac death [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/17\">",
"     17",
"    </a>",
"    ]. However, the yield of EMB is low using Dallas criteria. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/39/10874?source=see_link\">",
"     \"Natural history and therapy of myocarditis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Unexplained atrial fibrillation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Scant data are available on the role of EMB in patients with unexplained atrial fibrillation [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/19\">",
"     19",
"    </a>",
"    ]. We recommend against performing EMB in this setting; this recommendation is consistent with the 2007",
"    <span class=\"nowrap\">",
"     AHA/ACC/ESC",
"    </span>",
"    scientific statement [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Decisions regarding use of EMB should include consideration of the complications associated with the procedure.",
"   </p>",
"   <p>",
"    The risks of EMB include myocardial perforation with pericardial tamponade, arrhythmias, heart block, pneumothorax, arterial puncture, pulmonary embolization, nerve block or injury, hematoma, damage to the tricuspid valve, creation of arteriovenous fistula, and deep venous thrombosis. Reported complication rates range from less than 1 to as high as 6 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The overall safety of EMB was validated in a series of nearly 6800 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/20\">",
"     20",
"    </a>",
"    ]. The incidence of complications was 1.2 percent, with perforation occurring in 0.42 percent and death in 0.03 percent. The risk of myocardial perforation rises with the severity of left ventricular dilatation. Myocardial perforation can usually be managed conservatively with careful clinical and echocardiographic monitoring. Pericardiocentesis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    thoracotomy is required in selected cases, and death is rare.",
"   </p>",
"   <p>",
"    A later single-center experience of right ventricular biopsy via the femoral approach to evaluate unexplained left ventricular dysfunction also demonstrated low complication rates [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/3\">",
"     3",
"    </a>",
"    ]. The modified Cordis bioptome used is significantly more flexible and has smaller jaws than the standard Stanford-Caves bioptome. Retrospective study of 1919 patients undergoing 2505 EMB procedures and prospective study of 496 patients undergoing 543 EMB procedures revealed no patient deaths and no complications requiring emergency cardiac surgery. Major complications such as cardiac tamponade requiring pericardiocentesis or complete atrioventricular block requiring permanent pacing were very rare (0.12 percent total in the retrospective study and none in the prospective study). Minor complications such as pericardial effusion, conduction abnormalities, or arrhythmias occurred in 0.20 percent in the retrospective study and 5.5 percent in the prospective study.",
"   </p>",
"   <p>",
"    In a study of 755 patients undergoing LV, RV or biventricular EMB, LV EMB and RV EMB resulted in similar major complication rates (0.64 versus 0.82 percent) and similar minor complication rates (0.64 to 2.89 percent versus 2.24 to 5.10 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7592/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A complication that is primarily seen in cardiac transplant recipients who undergo repeated surveillance biopsies is development of significant tricuspid regurgitation (TR). The TR is usually well tolerated but valve replacement is infrequently required. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/24/28040?source=see_link&amp;anchor=H10#H10\">",
"     \"Acute cardiac allograft rejection: Diagnosis\", section on 'Complications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We recommend EMB in two clinical settings (in addition to monitoring for cardiac allograft rejection):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Unexplained new-onset HF of less than two weeks&rsquo; duration associated with a normal-sized or dilated left ventricle with hemodynamic compromise. (See",
"      <a class=\"local\" href=\"#H6474546\">",
"       'Fulminant HF'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Unexplained new-onset HF of two weeks to three months&rsquo; duration associated with a dilated left ventricle and new ventricular arrhythmias, Mobitz type II second-degree AV block, third-degree AV block, or failure to respond to usual care within one to two weeks. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Early AV block, arrhythmias or refractory HF'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We suggest EMB in selected patients in the following clinical settings when other evaluation is inconclusive:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Unexplained HF of more than three months&rsquo; duration associated with a dilated left ventricle and new ventricular arrhythmias, Mobitz type II second-degree block, third-degree atrioventricular block, or failure to respond to usual care within one to two weeks. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Late AV block, arrhythmias or refractory HF'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Unexplained HF with a dilated cardiomyopathy of any duration associated with a suspected allergic reaction in addition to eosinophilia. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'DCM with eosinophilia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Unexplained HF associated with suspected anthracycline cardiomyopathy if the cause of cardiac dysfunction is uncertain, in selected cases in which administration of greater than the usual upper limit of an agent is being considered, or clinical studies of toxicity of newer agents and regimens. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Anthracycline cardiotoxicity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      HF associated with unexplained restrictive cardiomyopathy. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Restrictive cardiomyopathy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In selected suspected cardiac tumors when indications for surgical removal are uncertain and EMB will likely alter management. Due to the risk of embolization EMB should not be performed if features are suggestive of myxoma. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Selected cardiac tumors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In selected children presenting with fulminant or acute unexplained HF, or idiopathic DCM. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Unexplained cardiomyopathy in children'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Heart failure associated with unexplained hypertrophic cardiomyopathy, if an infiltrative or storage disease is suspected and other evaluation is inconclusive. (See",
"      <a class=\"local\" href=\"#H5047314\">",
"       'HCM with HF'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Suspected arrhythmogenic right ventricular cardiomyopathy if other evaluation is inconclusive. (See",
"      <a class=\"local\" href=\"#H5047341\">",
"       'ARVC'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/22/32106?source=see_link\">",
"       \"Clinical manifestations and diagnosis of arrhythmogenic right ventricular cardiomyopathy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      EMB is of unproven value in the following settings. The potential utility of EMB in these settings is under investigation:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Recent onset (two weeks to three months&rsquo; duration) dilated cardiomyopathy (DCM) without new ventricular arrhythmias or Mobitz type II second-degree AV block, or third-degree AV block that responds to usual care within one to two weeks. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Recent onset DCM'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      EMB is generally not recommended for chronic DCM.",
"      <br/>",
"      <br/>",
"      An exception is suspected myocardial iron overload for which EMB can be helpful when other evaluation is inconclusive. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Chronic DCM'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/60/28617?source=see_link&amp;anchor=H14#H14\">",
"       \"Clinical manifestations of hereditary hemochromatosis\", section on 'Heart disease'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Unexplained arrhythmias. We suggest EMB in this setting only in exceptional cases in which the perceived likelihood of benefit outweighs the potential risk. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Unexplained arrhythmias'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Unexplained atrial fibrillation. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Unexplained atrial fibrillation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7592/abstract/1\">",
"      SAKAKIBARA S, KONNO S. Endomyocardial biopsy. Jpn Heart J 1962; 3:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7592/abstract/2\">",
"      Caves PK, Schulz WP, Dong E Jr, et al. New instrument for transvenous cardiac biopsy. Am J Cardiol 1974; 33:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7592/abstract/3\">",
"      Holzmann M, Nicko A, K&uuml;hl U, et al. Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period. Circulation 2008; 118:1722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7592/abstract/4\">",
"      Ardehali H, Howard DL, Hariri A, et al. A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy. Am Heart J 2005; 150:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7592/abstract/5\">",
"      Yilmaz A, Kindermann I, Kindermann M, et al. Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance. Circulation 2010; 122:900.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7592/abstract/6\">",
"      Cooper LT, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 2007; 116:2216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7592/abstract/7\">",
"      Vrana JA, Gamez JD, Madden BJ, et al. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood 2009; 114:4957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7592/abstract/8\">",
"      Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009; 119:e391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7592/abstract/9\">",
"      Heart Failure Society of America, Lindenfeld J, Albert NM, et al. HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail 2010; 16:e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7592/abstract/10\">",
"      McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33:1787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7592/abstract/11\">",
"      Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342:1077.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7592/abstract/12\">",
"      Kindermann I, Kindermann M, Kandolf R, et al. Predictors of outcome in patients with suspected myocarditis. Circulation 2008; 118:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7592/abstract/13\">",
"      Caforio AL, Calabrese F, Angelini A, et al. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J 2007; 28:1326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7592/abstract/14\">",
"      Frustaci A, Chimenti C, Calabrese F, et al. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 2003; 107:857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7592/abstract/15\">",
"      Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004; 109:1250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7592/abstract/16\">",
"      Lee JC, Seiler J, Blankstein R, et al. Images in cardiovascular medicine. Cardiac sarcoidosis presenting as heart block. Circulation 2009; 120:1550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7592/abstract/17\">",
"      Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 2009; 30:1995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7592/abstract/18\">",
"      Hill KD, Atkinson JB, Doyle TP, Dodd D. Routine performance of endomyocardial biopsy decreases the incidence of orthotopic heart transplant for myocarditis. J Heart Lung Transplant 2009; 28:1261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7592/abstract/19\">",
"      Frustaci A, Caldarulo M, Buffon A, et al. Cardiac biopsy in patients with \"primary\" atrial fibrillation. Histologic evidence of occult myocardial diseases. Chest 1991; 100:303.",
"     </a>",
"    </li>",
"    <li>",
"     Sekiguchi M, Take M. World survey of catheter biopsy of the heart. In: Cardiomyopathy: Clinical, Pathological and Theoretical Aspects, Sekiguchi M, Olsen EG (Eds), University Park Press, Baltimore 1980. p.217.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4923 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-199.231.185.123-2030A22EB4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_26_7592=[""].join("\n");
var outline_f7_26_7592=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TECHNIQUE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6476041\">",
"      Access and imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28739986\">",
"      Right or left ventricle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Sampling and analysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6475099\">",
"      Considerations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6475226\">",
"      EMB recommended",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6474546\">",
"      - Fulminant HF",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Early AV block, arrhythmias or refractory HF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6475344\">",
"      EMB suggested in selected cases",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Late AV block, arrhythmias or refractory HF",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - DCM with eosinophilia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Anthracycline cardiotoxicity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Restrictive cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Selected cardiac tumors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Unexplained cardiomyopathy in children",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5047314\">",
"      - HCM with HF",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5047341\">",
"      - ARVC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6475528\">",
"      EMB of unproven value",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Recent onset DCM",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Chronic DCM",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Unexplained arrhythmias",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Unexplained atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/4923\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/4923|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/58/30633\" title=\"picture 1\">",
"      Acute diffuse myocarditis Light",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/4923|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?34/56/35723\" title=\"table 1\">",
"      Diagnosis cardiac sarcoidosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/24/28040?source=related_link\">",
"      Acute cardiac allograft rejection: Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/31/1530?source=related_link\">",
"      An overview of amyloidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/45/17111?source=related_link\">",
"      Cardiac manifestations of Fabry disease and screening in patients with left ventricular hypertrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/19/17722?source=related_link\">",
"      Cardiac sarcoidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/32/17930?source=related_link\">",
"      Cardiac tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/46/41706?source=related_link\">",
"      Cardiotoxicity of anthracycline-like chemotherapy agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/10/23722?source=related_link\">",
"      Clinical manifestations and diagnosis of amyloid cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/22/32106?source=related_link\">",
"      Clinical manifestations and diagnosis of arrhythmogenic right ventricular cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/53/34647?source=related_link\">",
"      Clinical manifestations and diagnosis of myocarditis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/60/28617?source=related_link\">",
"      Clinical manifestations of hereditary hemochromatosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/42/36522?source=related_link\">",
"      Clinical manifestations, diagnosis, and evaluation of hypertrophic cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/12/12490?source=related_link\">",
"      Constrictive pericarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/3/30777?source=related_link\">",
"      Definition and classification of the cardiomyopathies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/3/29752?source=related_link\">",
"      Differentiating constrictive pericarditis and restrictive cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/28/22986?source=related_link\">",
"      Etiology and pathogenesis of myocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/28/39369?source=related_link\">",
"      Evaluation of the patient with heart failure or cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23207?source=related_link\">",
"      Idiopathic restrictive cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/39/10874?source=related_link\">",
"      Natural history and therapy of myocarditis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/19/35129?source=related_link\">",
"      Pathophysiology and diagnosis of iron overload syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/32/18952?source=related_link\">",
"      Treatment of hereditary hemochromatosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_26_7593="Pedunculated gastric carcinoid";
var content_f7_26_7593=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F81095%7EGAST%2F73158%7EGAST%2F53130&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F81095%7EGAST%2F73158%7EGAST%2F53130&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gastric carcinoid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 427px; height: 268px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power view demonstrates a solitary, pedunculated gastric carcinoid.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From Lewin KJ, Appelman HD. Tumors of the esophagus and stomach. Atlas of Tumor Pathology (electronic fascicle), Third series, Fascicle 18, 1996, Washington, DC. Armed Forces Institute of Pathology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Type I gastric carcinoids",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 389px; height: 313px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endoscopic picture of the gastric corpus in a patient with pernicious anemia demonstrates multiple polypoid masses that were shown to be carcinoids, type I.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From Lewin KJ, Appelman HD. Tumors of the esophagus and stomach. Atlas of Tumor Pathology (electronic fascicle), Third series, Fascicle 18, 1996, Washington, DC. Armed Forces Institute of Pathology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 537px\">",
"   <div class=\"ttl\">",
"    Gastric carcinoid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 517px; height: 227px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A total of three nodular appearing lesions were seen in the body of the stomach, measuring between 5 by 5 mm to 15 by 5 mm. Two had small ulcerations (arrows), which were presumably the site of bleeding. Image A represents a frontal view and image B is during retroflexion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Andres Gelrud, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_26_7593=[""].join("\n");
var outline_f7_26_7593=null;
var title_f7_26_7594="Etiology, clinical features, and diagnosis of cerebral venous thrombosis";
var content_f7_26_7594=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Etiology, clinical features, and diagnosis of cerebral venous thrombosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/26/7594/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/26/7594/contributors\">",
"     Jos&eacute; M Ferro, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/26/7594/contributors\">",
"     Patr&iacute;cia Canh&atilde;o, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/26/7594/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/26/7594/contributors\">",
"     Scott E Kasner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/26/7594/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/26/7594/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?7/26/7594/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 2, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cerebral vein and dural sinus thrombosis (CVT) is less common than most other types of stroke but can be more challenging to diagnose. Due to the widespread use of magnetic resonance imaging (MRI) and rising clinical awareness, CVT is recognized with increasing frequency. In addition, it is now known to have a more varied clinical spectrum than previously realized. Because of its myriad causes and presentations, CVT is a disease that may be encountered not only by neurologists and neurosurgeons, but also by internists, oncologists, hematologists, obstetricians, pediatricians, and family practitioners.",
"   </p>",
"   <p>",
"    This topic will review the epidemiology, pathogenesis, clinical features, and diagnosis of CVT. Prognosis and treatment are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/16/9482?source=see_link\">",
"     \"Treatment and prognosis of cerebral venous thrombosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;While high-quality epidemiologic studies of CVT are lacking, the available data suggest that CVT is uncommon [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/1\">",
"     1",
"    </a>",
"    ]. This conclusion is supported by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In large teaching hospitals, only 5 to 10 patients with CVT are admitted yearly [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/2\">",
"       2",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      A nationwide hospital-based series in Portugal that included patients admitted to all neurology services in the country identified 91 new cases of CVT, corresponding to an incidence of",
"      <span class=\"nowrap\">",
"       0.22/100,000",
"      </span>",
"      annually (95% CI, 0-0.47) [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/3\">",
"       3",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      A hospital-based population study from two provinces in the Netherlands identified 94 CVT adult cases over a three-year period, corresponding to an overall CVT incidence among adults of 1.32 per 100,000 population (95% CI, 1.06-1.61) [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/4\">",
"       4",
"      </a>",
"      ]. The annual incidence of CVT was higher for women compared with men (1.86 versus 0.75 per 100,000 population, respectively).",
"     </li>",
"     <li>",
"      In Isfahan, Iran, the incidence based upon hospital admissions was estimated to be",
"      <span class=\"nowrap\">",
"       1.23/100,000",
"      </span>",
"      per year [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/5\">",
"       5",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      The incidence of CVT in the multicenter Canadian registry in infants and children aged less than 18 years was",
"      <span class=\"nowrap\">",
"       0.67/100,000",
"      </span>",
"      per year [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/6\">",
"       6",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      A hospital discharge registry in the United States reported that the incidence of CVT during pregnancy was",
"      <span class=\"nowrap\">",
"       11.6/100,000",
"      </span>",
"      deliveries [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/7\">",
"       7",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In contrast, an autopsy study performed in the 1970s found a relatively high prevalence of CVT (9 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/8\">",
"     8",
"    </a>",
"    ]. However, this is likely an overestimate, as autopsy studies are biased to severe, fatal cases.",
"   </p>",
"   <p>",
"    Cerebral venous thrombosis is more common in women than men, with a female to male ratio of 3:1 [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. The imbalance may be due to the increased risk of CVT associated with pregnancy and puerperium and with oral contraceptives [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/11\">",
"     11",
"    </a>",
"    ]. The female predominance in CVT is found in young adults, but not in children or older adults [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/6,9\">",
"     6,9",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Etiology'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In the prospective International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT) cohort of 624 adults with CVT, women comprised 465 (75 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/10\">",
"     10",
"    </a>",
"    ]. Compared with men, women were significantly younger (mean age 34 years, versus 42 years for men). Furthermore, a gender specific risk factor &mdash; oral contraceptives, pregnancy, puerperium, and hormone replacement therapy &mdash; was identified in 65 percent of women. Women also had a better prognosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/16/9482?source=see_link&amp;anchor=H2#H2\">",
"     \"Treatment and prognosis of cerebral venous thrombosis\", section on 'Prognosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In hospital-based series, CVT is more common in neonates and children than in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/9,12\">",
"     9,12",
"    </a>",
"    ]. In addition, CVT is more common in neonates than it is in infants and children [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/6\">",
"     6",
"    </a>",
"    ]. In adults, CVT affects patients who are younger on average than those with arterial types of stroke. In the ISCVT, the mean age of patients with CVT was 39 years [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/9\">",
"     9",
"    </a>",
"    ], and only 8 percent of the patients were older than 65 [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of CVT remains incompletely understood because of the high variability in the anatomy of the venous system, and the paucity of experiments in animal models of CVT [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/14\">",
"     14",
"    </a>",
"    ]. However, there are at least two different mechanisms that may contribute to the clinical features of CVT (",
"    <a class=\"graphic graphic_algorithm graphicRef80911 \" href=\"UTD.htm?40/3/41022\">",
"     algorithm 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Thrombosis of cerebral veins or dural sinus leading to cerebral parenchymal lesions or dysfunction",
"     </li>",
"     <li>",
"      Occlusion of dural sinus resulting in decreased cerebrospinal fluid (CSF) absorption and elevated intracranial pressure",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Obstruction of the venous structures (",
"    <a class=\"graphic graphic_figure graphicRef72961 \" href=\"UTD.htm?17/9/17557\">",
"     figure 1",
"    </a>",
"    ) results in increased venous pressure, decreased capillary perfusion pressure, and increased cerebral blood volume. Dilatation of cerebral veins and recruitment of collateral pathways play an important role in the early phases of CVT and may initially compensate for changes in pressure.",
"   </p>",
"   <p>",
"    The increase in venous and capillary pressure leads to blood-brain barrier disruption, causing vasogenic edema, with leakage of blood plasma into the interstitial space. As intravenous pressure continues to increase, mild parenchymal changes, severe cerebral edema, and venous hemorrhage may occur due to venous or capillary rupture. The increased intravenous pressure may lead to an increase in intravascular pressure and a lowering of cerebral perfusion pressure, resulting in decreased cerebral blood flow (CBF) and failure of energy metabolism. In turn, this allows intracellular entry of water from failure of the",
"    <span class=\"nowrap\">",
"     Na+/K+",
"    </span>",
"    ATPase pump, and consequent cytotoxic edema [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Advances in understanding the pathophysiology of venous occlusion have been aided by the use of newer magnetic resonance imaging (MRI) methods, mainly diffusion-weighted MRI (DWI) and perfusion-weighted MRI (PWI) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/16-19\">",
"     16-19",
"    </a>",
"    ]. These techniques have demonstrated the coexistence of both cytotoxic and vasogenic edema in patients with CVT [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/16,18-20\">",
"     16,18-20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The other effect of venous thrombosis is impairment of CSF absorption. Normally, CSF absorption occurs in the arachnoid granulations, which drain CSF into the superior sagittal sinus. Thrombosis of the dural sinuses leads to increased venous pressure, impaired CSF absorption, and consequently elevated intracranial pressure. Elevated intracranial pressure is more frequent if superior sagittal sinus thrombosis is present, but it may also occur with thrombosis of the jugular or lateral sinus, producing a rise of pressure in the superior sagittal sinus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many causes or predisposing conditions are associated with CVT. The major risk factors for CVT in adults can be grouped as transient or permanent (",
"    <a class=\"graphic graphic_table graphicRef65303 \" href=\"UTD.htm?3/31/3581\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/1,9\">",
"     1,9",
"    </a>",
"    ]. The most frequent are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Prothrombotic conditions, either genetic or acquired (",
"      <a class=\"graphic graphic_table graphicRef52263 \" href=\"UTD.htm?4/21/4443\">",
"       table 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Oral contraceptives",
"     </li>",
"     <li>",
"      Pregnancy and the puerperium",
"     </li>",
"     <li>",
"      Malignancy",
"     </li>",
"     <li>",
"      Infection",
"     </li>",
"     <li>",
"      Head injury and mechanical precipitants",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In more than 85 percent of adult patients, at least one risk factor for CVT can be identified, most often a prothrombotic condition [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/9\">",
"     9",
"    </a>",
"    ]. In the ISCVT cohort, a prothrombotic condition was found in 34 percent of all patients, and a genetic prothrombotic condition was found in 22 percent of all patients [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/9\">",
"     9",
"    </a>",
"    ]. Although infectious causes of CVT were frequently reported in the past, they are responsible for only 6 to 12 percent of cases in modern-era studies of adults with CVT [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/9,21\">",
"     9,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As with venous thrombosis in other parts of the body, multiple risk factors may be found in about half of adult patients with CVT [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/9\">",
"     9",
"    </a>",
"    ]. In light of this, a thorough search for additional causes should be carried out even when a specific risk factor is identified in a given patient. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43786?source=see_link\">",
"     \"Overview of the causes of venous thrombosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    No underlying etiology or risk factor for CVT is found in approximately 13 percent of adult patients. However, it is important to continue searching for a cause even after the acute phase of CVT, as some patients may have a condition such as the antiphospholipid syndrome, polycythemia, thrombocythemia, or malignancy that is discovered weeks or months after the acute phase.",
"   </p>",
"   <p>",
"    The risk for CVT is influenced by the individual's genetic background [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/22\">",
"     22",
"    </a>",
"    ]. In the presence of some prothrombotic conditions, patients are at an increased risk of developing a CVT when exposed to a precipitant such a head trauma, lumbar puncture, jugular catheter placement, pregnancy, surgery, infection, and drugs. These prothrombotic conditions include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Antithrombin deficiency [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/21\">",
"       21",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Protein C deficiency or protein S deficiency [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/6,23,24\">",
"       6,23,24",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Factor V Leiden mutation [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/25-27\">",
"       25-27",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      G20210 A prothrombin gene mutation [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/26-29\">",
"       26-29",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The association of CVT with hyperhomocysteinemia due to gene mutations in methylene tetrahydrofolate reductase (MTHFR) is controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/22,30,31\">",
"     22,30,31",
"    </a>",
"    ]",
"   </p>",
"   <p>",
"    The risk factors associated with CVT vary throughout life.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the Canadian pediatric ischemic stroke registry, a risk factor was identified in 98 percent of the children [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In neonates, acute systemic illness, such as perinatal complications and dehydration, occurred in 84 percent of patients [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/6\">",
"       6",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/2/27690?source=see_link&amp;anchor=H18#H18\">",
"       \"Stroke in the newborn\", section on 'Cerebral sinovenous thrombosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A prothrombotic state was found in 41 percent of the patients, most often in infants older than four weeks of age and children.",
"     </li>",
"     <li>",
"      In infants older than four weeks of age and in children, head and neck disorders, mostly infections and chronic systemic diseases (eg, connective tissue disease, hematologic disorder, and cancer) were common.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a meta-analysis of case-control studies, with over 200 neonatal and pediatric cases of sinovenous thrombosis (ie, CVT), and 1200 control subjects, the prevalence of factor V Leiden (FVL) mutation among cases and controls was 12.8 and 3.6 percent respectively, and carriers of the FVL mutation were significantly more likely to develop CVT (odds ratio [OR] 3.1, 95% CI 1.8-5.5) [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/32\">",
"       32",
"      </a>",
"      ]. Similarly, the prevalence of the prothrombin gene mutation among cases and controls was 5.2 and 2.5 percent, respective, and carriers were significantly more likely to develop CVT (OR 3.1, 95% CI 1.4-6.8).",
"     </li>",
"     <li>",
"      A 2010 meta-analysis of case-control studies found that the frequency of the MTHFR 677C&gt;T polymorphism in adults was similar for 382 patients with CVT compared with 1217 controls (15.7 versus 14.6 percent; OR 1.12, 95% CI 0.8-1.58), suggesting that the MTHFR 677C&gt;T polymorphism is",
"      <strong>",
"       not",
"      </strong>",
"      a risk factor for CVT [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/33\">",
"       33",
"      </a>",
"      ]. In contrast, a 2011 meta-analysis, after controlling for heterogeneity among studies, found that the MTHFR 677C&gt;T polymorphism was associated with CVT (OR 2.30, 95% CI 1.20-4.42) [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The most frequent risk factor in young women is the use of oral contraceptives. Two case-control studies have shown an increased risk of sinus thrombosis in women who use oral contraceptives [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/26,34\">",
"       26,34",
"      </a>",
"      ]. Furthermore, the risk for CVT in women using oral contraceptives is increased if they have a prothrombotic defect [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In elderly CVT patients, the proportion of cases without identified risk factors is higher (37 percent) than it is in adults under age 65. The most common risk factors in those &ge;65 years old are genetic or acquired thrombophilia, malignancy, and hematologic disorders such as polycythemia [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL ASPECTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cerebral vein and dural sinus thrombosis (CVT) has a highly variable clinical presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/21,35\">",
"     21,35",
"    </a>",
"    ]. The onset can be acute, subacute, or chronic. A case of CVT mimicking a transient ischemic attack has also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Symptoms and signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms and signs of CVT can be grouped in three major syndromes:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Isolated intracranial hypertension syndrome (headache with or without vomiting, papilledema, and visual problems) [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/37\">",
"       37",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Focal syndrome (focal deficits, seizures, or both)",
"     </li>",
"     <li>",
"      Encephalopathy (multifocal signs, mental status changes, stupor, or coma) [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/3,21\">",
"       3,21",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Headache",
"    </span>",
"    &nbsp;&mdash;&nbsp;Headache is the most frequent symptom of CVT. In the ISCVT cohort, headache was present in 89 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/9\">",
"     9",
"    </a>",
"    ]. Headaches associated with CVT are more frequent in women and young patients than in men or older adults. Headache is usually the first symptom of CVT, and can be the only symptom [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/38\">",
"     38",
"    </a>",
"    ], or can precede other symptoms and signs by days or weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The features of CVT-related headache are quite variable:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Head pain is more often localized than diffuse [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/39\">",
"       39",
"      </a>",
"      ]. However, the site of the headache has no relationship with the localization of the occluded sinus or the parenchymal lesions [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/40,41\">",
"       40,41",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Headache onset is usually gradual, increasing over several days [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/11\">",
"       11",
"      </a>",
"      ]. However, some patients with CVT have sudden explosive onset of severe head pain (ie, thunderclap headache) that mimics subarachnoid hemorrhage [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/42,43\">",
"       42,43",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/19/12601?source=see_link\">",
"       \"Thunderclap headache\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38522?source=see_link\">",
"       \"Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Headache caused by intracranial hypertension from CVT is typically characterized by severe, dull, generalized head pain that worsens with Valsalva maneuvers and with recumbency. Visual obscurations may occur, coinciding with bouts of increased headache intensity.",
"     </li>",
"     <li>",
"      Headache may resemble migraine with aura [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/44-46\">",
"       44-46",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/4/26698?source=see_link\">",
"       \"Pathophysiology, clinical manifestations, and diagnosis of migraine in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/25/8600?source=see_link\">",
"       \"Pathophysiology, clinical features, and diagnosis of migraine in children\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    CVT must also be included as a possible cause of persisting headache following lumbar puncture, because lumbar puncture can rarely precipitate a CVT. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/46/20198?source=see_link\">",
"     \"Post-lumbar puncture headache\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Encephalopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disturbances of consciousness and cognitive dysfunction, such as delirium, apathy, a frontal lobe syndrome, multifocal deficits, or seizures, can be present in severe cases of CVT.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Focal symptoms and signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Motor weakness with monoparesis or hemiparesis, sometimes bilateral, is the most frequent focal deficit associated with CVT. In the ISCVT cohort, motor weakness was present in 37 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/9\">",
"     9",
"    </a>",
"    ]. Aphasia, in particular of the fluent type, may follow sinus thrombosis, especially when the left lateral sinus is affected. Sensory deficits and visual field defects are less common.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Seizures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Focal or generalized seizures, including status epilepticus, are more frequent in CVT than in other stroke types. In the ISCVT cohort of 624 patients, seizures at presentation occurred in 39 percent, and seizures after the diagnosis of CVT occurred in 7 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/47\">",
"     47",
"    </a>",
"    ]. In a retrospective cohort of 70 children (including 25 neonates) with CVT, seizures at presentation occurred in 20 of 45 non-neonates (44 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Variables associated with seizures include supratentorial parenchymal brain lesions, sagittal sinus and cortical vein thrombosis, and motor deficits [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Variables affecting presentation and course",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical symptoms and signs in CVT depend on several factors:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Site and number of occluded sinus and veins.",
"     </li>",
"     <li>",
"      Presence of parenchymal brain lesions &mdash; Cerebral edema, venous infarction, and hemorrhagic venous infarctions are associated with a more severe syndrome. Patients are more likely to be comatose or to have motor deficits, aphasia, and seizures, and less likely to present with isolated headache.",
"     </li>",
"     <li>",
"      Patient age [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/6,9,13\">",
"       6,9,13",
"      </a>",
"      ] &mdash; In children, signs of diffuse brain injury, coma, and seizures are the main clinical manifestations, especially in neonates. In older children, the manifestations of CVT resemble those in adults, with headache and hemiparesis [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/12\">",
"       12",
"      </a>",
"      ]. Elderly patients also have a distinctive presentation; vigilance and mental problems are more common while headaches and isolated intracranial hypertension are less frequent than in younger patients [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Gender &mdash; Women are more likely than men to have a headache on presentation, and less likely to have a chronic onset of symptoms [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Interval from CVT onset to presentation [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/49\">",
"       49",
"      </a>",
"      ] &mdash; Isolated intracranial hypertension is more frequent in patients with a chronic presentation than in those who present acutely. In addition, patients with chronic course or delayed clinical presentation may show papilledema on funduscopy, a finding that is less frequent in acute cases. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/53/30552?source=see_link\">",
"       \"Overview and differential diagnosis of papilledema\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Isolated sinus and vein thrombosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Isolated thrombosis of the different sinus and veins produces diverse clinical pictures.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In cavernous sinus thrombosis, ocular signs dominate the clinical picture with orbital pain, chemosis, proptosis, and oculomotor palsies. Isolated cortical vein occlusion produces",
"      <span class=\"nowrap\">",
"       motor/sensory",
"      </span>",
"      deficits and seizures [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/50-52\">",
"       50-52",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      With sagittal sinus occlusion, motor deficits, bilateral deficits, and seizures are frequent, while presentation as an isolated intracranial hypertension syndrome is infrequent.",
"     </li>",
"     <li>",
"      Patients with isolated lateral sinus thrombosis frequently present with isolated headache or isolated intracranial hypertension [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/53\">",
"       53",
"      </a>",
"      ]. Less often, they may also present with focal deficits or seizures. Aphasia often follows if the left transverse sinus is occluded.",
"     </li>",
"     <li>",
"      Jugular vein or lateral sinus thrombosis may present as isolated pulsating tinnitus [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/54,55\">",
"       54,55",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Multiple cranial nerve palsies may occur in thrombosis of the lateral sinus [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/56\">",
"       56",
"      </a>",
"      ], jugular, or posterior fossa veins thrombosis.",
"     </li>",
"     <li>",
"      When the deep cerebral venous system (ie, the straight sinus and its branches) is occluded, the signs and symptoms of CVT are generally severe, with coma, mental problems, and motor deficits, often bilateral [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/57-59\">",
"       57-59",
"      </a>",
"      ]. However, more limited thrombosis of the deep venous system can produce relatively mild symptoms [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/60\">",
"       60",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Neuroimaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;The neuroimaging features of CVT include findings that suggest the primary underlying pathology of venous thrombosis and associated brain parenchymal lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/1\">",
"     1",
"    </a>",
"    ]. These may include focal areas of edema or venous infarction, hemorrhagic venous infarction, diffuse brain edema, or (rarely) isolated subarachnoid hemorrhage. In patients with CVT, the proportion who present with intracerebral hemorrhage is 30 to 40 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/61,62\">",
"     61,62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Guidelines from the American Heart",
"    <span class=\"nowrap\">",
"     Association/American",
"    </span>",
"    Stroke Association",
"    <span class=\"nowrap\">",
"     (AHA/ASA)",
"    </span>",
"    published in 2011 state that imaging of the cerebral venous system should be performed in patients with lobar intracerebral hemorrhage of otherwise unclear origin or with cerebral infarction that crosses typical arterial boundaries [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/1\">",
"     1",
"    </a>",
"    ]. In addition, the guidelines conclude that imaging of the cerebral venous system should be performed for patients with the clinical features of idiopathic intracranial hypertension, and that imaging of the cerebral venous system is reasonable to exclude CVT in patients with headache associated with atypical features.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     MRI",
"    </span>",
"    &nbsp;&mdash;&nbsp;MRI using gradient echo T2* susceptibility-weighted sequences in combination with MR venography is the most sensitive imaging method for demonstrating the thrombus and the occluded dural sinus or vein (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef74617 \" href=\"UTD.htm?22/13/22740\">",
"     image 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/20,63-68\">",
"     20,63-68",
"    </a>",
"    ]. The characteristics of the MRI signal depend on the age of the thrombus [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/63,69\">",
"     63,69",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      In the first five days, the thrombosed sinuses appear isointense on T1-weighted images and hypointense on T2-weighted images",
"     </li>",
"     <li>",
"      Beyond five days, venous thrombus becomes more apparent because signal is increased on both T1 and T2-weighted images",
"     </li>",
"     <li>",
"      After the first month, thrombosed sinuses exhibit a variable pattern of signal, which may appear isointense",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    On gradient echo T2*-weighted MRI sequences, the clot can be directly visualized as an area of hypointensity in the affected cortical vein",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    sinus [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/52,65,70\">",
"     52,65,70",
"    </a>",
"    ]. However, a chronically thrombosed sinus may still demonstrate low signal on these sequences. Limited data from a series of 28 patients with CVT suggest that the presence of hyperintensities in the veins or sinuses on diffusion-weighted MRI sequences predicts a low recanalization rate [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Parenchymal brain lesions secondary to venous occlusion, including brain swelling, edema, or venous infarction, appear as hypointense or isointense on T1-weighted MRI, and hyperintense on T2-weighted MRI (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82376 \" href=\"UTD.htm?6/6/6243\">",
"     image 2",
"    </a>",
"    ). Hemorrhagic venous infarcts appear as hyperintense lesions on both MRI sequences (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef71338 \" href=\"UTD.htm?36/38/37473\">",
"     image 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H174063473\">",
"    <span class=\"h3\">",
"     MR venography",
"    </span>",
"    &nbsp;&mdash;&nbsp;MR venography, usually performed using the time-of-flight (TOF) technique, is useful for demonstrating absence of flow in cerebral venous sinuses, though interpretation can be confounded by normal anatomic variants such as sinus hypoplasia and asymmetric flow (see",
"    <a class=\"local\" href=\"#H16\">",
"     'Diagnosis'",
"    </a>",
"    below) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/1\">",
"     1",
"    </a>",
"    ]. Other MR techniques may be useful to distinguish these variants from venous thrombosis. Contrast-enhanced MR venography can provide better visualization of cerebral venous channels, and gradient echo or susceptibility-weighted sequences will show normal signal in a hypoplastic sinus and abnormally low signal in the presence of thrombus. A chronically thrombosed hypoplastic sinus will show absence of flow on two-dimensional TOF MR venography and enhancement on contrast-enhanced MRI and MR venography.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Head CT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Head CT is normal in up to 30 percent of CVT cases, and most of the findings are nonspecific [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/21\">",
"     21",
"    </a>",
"    ]. However, CT is often the first investigation to be performed in clinical practice, and it is useful to rule out other acute or subacute cerebral disorders.",
"   </p>",
"   <p>",
"    In about one-third of cases, CT demonstrates direct signs of CVT, which are as follows (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef59194 \" href=\"UTD.htm?13/14/13537\">",
"     image 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/21,72-74\">",
"     21,72-74",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The dense triangle sign, seen on noncontrast head CT as a hyperdensity with a triangular or round shape in the posterior part of the superior sagittal sinus caused by the venous thrombus",
"     </li>",
"     <li>",
"      The empty delta sign (also called the empty triangle or negative delta sign), seen on head CT with contrast as a triangular pattern of contrast enhancement surrounding a central region lacking contrast enhancement in the posterior part of the superior sagittal sinus",
"     </li>",
"     <li>",
"      The cord sign, usually seen on head CT with contrast as a curvilinear or linear hyperdensity over the cerebral cortex caused by a thrombosed cortical vein",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Indirect signs of CVT on head CT are more frequent. These can include intense contrast enhancement of falx and tentorium, dilated transcerebral veins, small ventricles, and parenchyma abnormalities. In addition, associated brain lesions may be depicted in 60 to 80 percent of patients with CVT. These may be hemorrhagic or nonhemorrhagic:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hemorrhagic lesions include intracerebral hemorrhage, hemorrhagic infarcts, or rarely (&lt;1 percent) subarachnoid hemorrhage usually limited to the convexity [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/75-77\">",
"       75-77",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Nonhemorrhagic lesions included focal areas of hypodensity caused by edema or venous infarction usually not respecting the arterial boundaries, and diffuse brain edema may. With serial imaging, some lesions may disappear (\"vanishing infarcts\"), and new lesions may appear.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6837204\">",
"    <span class=\"h3\">",
"     CT venography",
"    </span>",
"    &nbsp;&mdash;&nbsp;CT venography gives a good visualization of the major dural sinuses, is readily available, can be used for patients who have contraindications to MRI (eg, pacemaker) and is quicker than MRI [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/1\">",
"     1",
"    </a>",
"    ]. CT venography is often particularly helpful in subacute or chronic CVT because it can demonstrate heterogeneous density in thrombosed venous sinuses. However, its use may be limited because of low resolution of the deep venous system and cortical veins, the risk of contrast reactions, and radiation exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/66,78,79\">",
"     66,78,79",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with clinically suspected CVT, the clear demonstration of absence of flow and intraluminal venous thrombus by CT or MRI is the most important finding for confirming the diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/1\">",
"     1",
"    </a>",
"    ]. However, these findings are not always evident, and the diagnosis may rest on imaging features showing only absence of flow in a venous sinus or cortical vein. In such cases, clinicians should be aware of the potential for diagnostic pitfalls. A number of normal anatomic variants may mimic sinus thrombosis, including sinus atresia, sinus hypoplasia, asymmetric sinus drainage, and normal sinus filling defects associated with arachnoid granulations or intrasinus septa [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/1\">",
"     1",
"    </a>",
"    ]. For example, a study of 100 subjects (without CVT) with normal brain MRI found artifactual transverse sinus flow gaps on MR venography (in nondominant or codominant but not in dominant transverse sinuses) in 31 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/80\">",
"     80",
"    </a>",
"    ] and another report of 100 subjects without venous pathology found asymmetric lateral sinuses in 49 percent, and partial or total absence of one lateral sinus in 20 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/81\">",
"     81",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Agreement between observers for the diagnosis of CVT with MRI varies with the location of sinus or vein thrombosis. It is good or very good for most of the occluded sinus and veins; moderate to very good for the left lateral sinus and straight sinus; and poor to good for the cortical veins [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/82\">",
"     82",
"    </a>",
"    ]. The diagnosis of isolated cortical vein thrombosis remains difficult to establish with MR venography. Use of T2*-weighted MRI may enable a diagnosis of isolated cortical vein thrombosis by demonstrating clot as an area of hypointensity [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/52,65,70\">",
"     52,65,70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Since head CT is often normal in patients with CVT, confirmation may require MRI techniques that are not readily available in some hospitals and geographic locations. CT venography is a useful alternative to MR venography or intra-arterial angiography for the diagnosis of CVT, demonstrating filling defects, sinus wall enhancement, and increased collateral venous drainage [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/83,84\">",
"     83,84",
"    </a>",
"    ]. When combined with head CT, it adds considerable information in suspected cases of CVT [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/85\">",
"     85",
"    </a>",
"    ]. The overall accuracy of head CT combined with CT venography is 90 to 100 percent, depending on the occlusion site [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/78\">",
"     78",
"    </a>",
"    ]. Guidelines from the",
"    <span class=\"nowrap\">",
"     AHA/ASA",
"    </span>",
"    published in 2011 consider CT venography to be at least equivalent to MR venography in the diagnosis of CVT [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/1\">",
"     1",
"    </a>",
"    ]. Compared with digital subtraction intra-arterial angiography, the combination of head CT and CT venography has a sensitivity and specificity of 95 and 91 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/85\">",
"     85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cerebral intraarterial angiography is recommended mainly when the diagnosis of CVT is uncertain, such as in the rare suspected cases of isolated cortical vein thrombosis, or when the clinical suspicion for CVT is high but CT venography or MR venography are inconclusive [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/1\">",
"     1",
"    </a>",
"    ]. Angiography may be helpful for making this diagnosis by showing the sudden termination of a cortical vein surrounded by dilated and tortuous collateral \"corkscrew veins,\" or by the filling of a cortical vein that was not apparent on an earlier angiographic study during the acute phase of CVT. Other typical signs of CVT on intraarterial angiography are nonvisualization of all or part of a venous sinus, delayed venous emptying with pathologically increased collaterals, and reversal of venous flow.",
"   </p>",
"   <p>",
"    As with MR and CT venography, conventional cerebral angiography may be limited by potential pitfalls. Anatomic variations, such as variability of number and location of cortical veins, hypoplasia of the anterior part of the superior sagittal sinus, duplication of the superior sagittal sinus, and hypoplasia or aplasia of the transverse sinuses, may make the diagnosis of CVT by all types of angiography difficult [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/21\">",
"     21",
"    </a>",
"    ]. While the interobserver agreement for a diagnosis of CVT is not perfect, the combination of conventional contrast angiography plus brain MRI has a higher interobserver agreement than angiography alone (94 versus 62 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/86\">",
"     86",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Transcranial Doppler ultrasonography [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/87,88\">",
"     87,88",
"    </a>",
"    ] and transcranial power or color Doppler imaging, with or without the use of contrast [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/89-91\">",
"     89-91",
"    </a>",
"    ], are noninvasive techniques that have potential utility for the diagnosis of CVT and for follow-up, but more information is needed to determine the true clinical value of these methods. In pediatric patients, transfontanellar ultrasound may support the diagnosis of CVT [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Laboratory tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aside from neuroimaging, there is no simple confirmatory laboratory test that can confidently rule out CVT in the acute phase of the disease. Current guidelines from the",
"    <span class=\"nowrap\">",
"     AHA/ASA",
"    </span>",
"    recommend obtaining routine blood studies consisting of a complete blood count, chemistry panel, prothrombin time, and activated partial thromboplastin time for patients with suspected CVT [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/1\">",
"     1",
"    </a>",
"    ]. The findings from these tests may suggest the presence of conditions that contribute to the development of CVT such as an underlying hypercoagulable state, infection, or inflammatory process. The guidelines recommend screening for these and other potential prothrombotic conditions that may predispose to CVT, including use of contraceptives, at the initial clinical presentation.",
"   </p>",
"   <p>",
"    The utility of D-dimer testing and lumbar puncture is less certain [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An elevated D-dimer level supports the diagnosis of CVT [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/92-94\">",
"       92-94",
"      </a>",
"      ], but a normal D-dimer does not exclude the diagnosis in patients with suggestive symptoms and predisposing factors. As many as 10 percent of all patients with CVT and 26 percent of those who present with isolated headache may have normal D-dimer values [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/95\">",
"       95",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Lumbar puncture may be useful to exclude meningitis in patients with CVT who present with isolated intracranial hypertension, a syndrome that may account for up to 25 percent of all patients with CVT [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/9\">",
"       9",
"      </a>",
"      ]. In addition, lumbar puncture is valuable in such patients to measure and decrease cerebrospinal fluid pressure when vision is threatened. However, in the absence of suspicion for meningitis, cerebrospinal fluid analysis is usually not helpful diagnostically for patients with focal neurologic findings and neuroimaging confirmation of CVT [",
"      <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The cerebrospinal fluid abnormalities in CVT are nonspecific and may include a lymphocytic pleocytosis, elevated red blood cell count, and elevated protein; these abnormalities are present in 30 to 50 percent of patients with CVT [",
"    <a class=\"abstract\" href=\"UTD.htm?7/26/7594/abstract/35,37\">",
"     35,37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Evaluation for the cause of CVT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Searching for a thrombophilic state, either genetic or acquired, should be done in all patients. Screening should include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Antithrombin",
"     </li>",
"     <li>",
"      Protein C",
"     </li>",
"     <li>",
"      Protein S",
"     </li>",
"     <li>",
"      Factor V Leiden",
"     </li>",
"     <li>",
"      Prothrombin G20210A mutation",
"     </li>",
"     <li>",
"      Lupus anticoagulant, anticardiolipin, and anti-&beta;2 glycoprotein-I antibodies",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Acute thrombosis can transiently reduce levels of antithrombin, protein C, and protein S, so the utility of testing for these disorders in the acute phase of CVT is limited. In practice, it is preferable to test for protein C, protein S, and antithrombin at least two weeks after oral anticoagulation has been discontinued, since",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    therapy reduces measurements of protein C and protein S, and may raise plasma antithrombin concentrations into the normal range in patients with hereditary antithrombin deficiency. It is possible to test for protein C and protein S levels while receiving",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    therapy, which does not alter plasma protein C or protein S concentrations. However, testing for antithrombin should be performed when off heparin, which can lower antithrombin levels. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/36/24136?source=see_link\">",
"     \"Antithrombin (ATIII) deficiency\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/52/841?source=see_link\">",
"     \"Protein C deficiency\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/55/13176?source=see_link\">",
"     \"Protein S deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If abnormal results are found in assays for lupus anticoagulant, anticardiolipin, or anti-&beta;2 glycoprotein-I antibodies, testing should be repeated at least 12 weeks later, as the diagnosis of antiphospholipid syndrome is strengthened by two positive determinations of these biomarkers. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/29/27096?source=see_link&amp;anchor=H60490098#H60490098\">",
"     \"Diagnosis of the antiphospholipid syndrome\", section on 'Initial laboratory testing'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients older than 40 years without identified etiology, we suggest searching for an occult malignancy. In patients with sepsis, or with fever and no obvious cause of infection, we recommend performing a lumbar puncture.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cerebral venous thrombosis (CVT) is uncommon, with an overall incidence of &lt;1.5 per 100,000 annually. The disorder is more common in neonates and children than in adults, and among young adults more common in women than men. The mean age of onset is 39 years old. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      At least two mechanisms may contribute to the clinical features of CVT (",
"      <a class=\"graphic graphic_algorithm graphicRef80911 \" href=\"UTD.htm?40/3/41022\">",
"       algorithm 1",
"      </a>",
"      ):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Thrombosis of cerebral veins or dural sinus (",
"      <a class=\"graphic graphic_figure graphicRef72961 \" href=\"UTD.htm?17/9/17557\">",
"       figure 1",
"      </a>",
"      ) leads to increased venous and capillary pressure, which in turn may result in cerebral edema, venous hemorrhage,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      ischemia with cytotoxic edema.",
"     </li>",
"     <li>",
"      Occlusion of dural sinus causes decreased cerebrospinal fluid absorption and elevated intracranial pressure. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The major risk factors for CVT in adults (",
"      <a class=\"graphic graphic_table graphicRef65303 \" href=\"UTD.htm?3/31/3581\">",
"       table 1",
"      </a>",
"      ) are prothrombotic (hypercoagulable) conditions (",
"      <a class=\"graphic graphic_table graphicRef52263 \" href=\"UTD.htm?4/21/4443\">",
"       table 2",
"      </a>",
"      ), oral contraceptives, pregnancy and the puerperium, malignancy, infection, head injury, and mechanical precipitants. In neonates, perinatal complications and dehydration are major risk factors. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical presentation of CVT is highly variable. The onset can be acute, subacute, or chronic. Headache (of gradual, acute, or thunderclap onset) is the most frequent symptom, occurring in almost 90 percent of patients, and may occur as part of an isolated intracranial hypertension syndrome, with or without vomiting, papilledema, and visual problems. In other cases, headache may be accompanied by common symptoms of CVT, including focal neurologic deficits, focal or generalized seizures, and encephalopathy with altered mental status, stupor, or coma. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical aspects'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Parenchymal brain lesions, including brain swelling, edema, venous infarction, or hemorrhagic venous infarction, may occur secondary to venous occlusion. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Neuroimaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Brain MRI in combination with MR venography is the most sensitive examination technique for demonstrating the thrombus and the occluded dural sinus or vein. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Neuroimaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Head CT scan is normal in up to 30 percent of CVT cases, and most of the findings with CVT are nonspecific. However, in about one-third of patients, CT demonstrates direct signs of CVT, which are the empty delta sign, the cord sign, and the dense triangle sign. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Neuroimaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The combination of an abnormal signal in a venous sinus on brain MRI and the corresponding absence of flow on MR venography confirms the diagnosis of CVT. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      CT venography is a useful alternative to MR venography for the diagnosis of CVT, demonstrating filling defects, sinus wall enhancement, and increased collateral venous drainage. The overall accuracy of head CT combined with CT venography is 90 to 100 percent, depending on the occlusion site. Current guidelines consider CT venography to be at least equivalent to MR venography in the diagnosis of CVT. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/1\">",
"      Saposnik G, Barinagarrementeria F, Brown RD Jr, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42:1158.",
"     </a>",
"    </li>",
"    <li>",
"     Unpublished data, International study on cerebral vein and dural sinus thrombosis (ISCVT) and Cerebral venous thrombosis Portuguese collaborative study group (VENOPORT) registries.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/3\">",
"      Ferro JM, Correia M, Pontes C, et al. Cerebral vein and dural sinus thrombosis in Portugal: 1980-1998. Cerebrovasc Dis 2001; 11:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/4\">",
"      Coutinho JM, Zuurbier SM, Aramideh M, Stam J. The incidence of cerebral venous thrombosis: a cross-sectional study. Stroke 2012; 43:3375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/5\">",
"      Saadatnia M, Mousavi SA, Haghighi S, Aminorroaya A. Cerebral vein and sinus thrombosis in Isfahan-Iran: a changing profile. Can J Neurol Sci 2004; 31:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/6\">",
"      deVeber G, Andrew M, Adams C, et al. Cerebral sinovenous thrombosis in children. N Engl J Med 2001; 345:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/7\">",
"      Lanska DJ, Kryscio RJ. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke 2000; 31:1274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/8\">",
"      Towbin A. The syndrome of latent cerebral venous thrombosis: its frequency and relation to age and congestive heart failure. Stroke 1973; 4:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/9\">",
"      Ferro JM, Canh&atilde;o P, Stam J, et al. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004; 35:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/10\">",
"      Coutinho JM, Ferro JM, Canh&atilde;o P, et al. Cerebral venous and sinus thrombosis in women. Stroke 2009; 40:2356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/11\">",
"      Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med 2005; 352:1791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/12\">",
"      Lancon JA, Killough KR, Tibbs RE, et al. Spontaneous dural sinus thrombosis in children. Pediatr Neurosurg 1999; 30:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/13\">",
"      Ferro JM, Canh&atilde;o P, Bousser MG, et al. Cerebral vein and dural sinus thrombosis in elderly patients. Stroke 2005; 36:1927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/14\">",
"      Schaller B, Graf R. Cerebral venous infarction: the pathophysiological concept. Cerebrovasc Dis 2004; 18:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/15\">",
"      Gotoh M, Ohmoto T, Kuyama H. Experimental study of venous circulatory disturbance by dural sinus occlusion. Acta Neurochir (Wien) 1993; 124:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/16\">",
"      Corvol JC, Oppenheim C, Mana&iuml; R, et al. Diffusion-weighted magnetic resonance imaging in a case of cerebral venous thrombosis. Stroke 1998; 29:2649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/17\">",
"      L&ouml;vblad KO, Bassetti C, Schneider J, et al. Diffusion-weighted mr in cerebral venous thrombosis. Cerebrovasc Dis 2001; 11:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/18\">",
"      Yoshikawa T, Abe O, Tsuchiya K, et al. Diffusion-weighted magnetic resonance imaging of dural sinus thrombosis. Neuroradiology 2002; 44:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/19\">",
"      R&ouml;ther J, Waggie K, van Bruggen N, et al. Experimental cerebral venous thrombosis: evaluation using magnetic resonance imaging. J Cereb Blood Flow Metab 1996; 16:1353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/20\">",
"      Chu K, Kang DW, Yoon BW, Roh JK. Diffusion-weighted magnetic resonance in cerebral venous thrombosis. Arch Neurol 2001; 58:1569.",
"     </a>",
"    </li>",
"    <li>",
"     Bousser MG, Russell RR. Cerebral venous thrombosis. In: Major Problems in Neurology, Warlow CP, Van Gijn J (Eds), WB Saunders, London 1997. p.27, 104.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/22\">",
"      Marjot T, Yadav S, Hasan N, et al. Genes associated with adult cerebral venous thrombosis. Stroke 2011; 42:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/23\">",
"      Enevoldson TP, Russell RW. Cerebral venous thrombosis: new causes for an old syndrome? Q J Med 1990; 77:1255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/24\">",
"      Deschiens MA, Conard J, Horellou MH, et al. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke 1996; 27:1724.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/25\">",
"      L&uuml;demann P, Nabavi DG, Junker R, et al. Factor V Leiden mutation is a risk factor for cerebral venous thrombosis: a case-control study of 55 patients. Stroke 1998; 29:2507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/26\">",
"      Martinelli I, Sacchi E, Landi G, et al. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 1998; 338:1793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/27\">",
"      Weih M, Junge-H&uuml;lsing J, Mehraein S, et al. [Hereditary thrombophilia with ischemiC stroke and sinus thrombosis. Diagnosis, therapy and meta-analysis]. Nervenarzt 2000; 71:936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/28\">",
"      Biousse V, Conard J, Brouzes C, et al. Frequency of the 20210 G--&gt;A mutation in the 3'-untranslated region of the prothrombin gene in 35 cases of cerebral venous thrombosis. Stroke 1998; 29:1398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/29\">",
"      Reuner KH, Ruf A, Grau A, et al. Prothrombin gene G20210--&gt;A transition is a risk factor for cerebral venous thrombosis. Stroke 1998; 29:1765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/30\">",
"      Hillier CE, Collins PW, Bowen DJ, et al. Inherited prothrombotic risk factors and cerebral venous thrombosis. QJM 1998; 91:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/31\">",
"      Cantu C, Alonso E, Jara A, et al. Hyperhomocysteinemia, low folate and vitamin B12 concentrations, and methylene tetrahydrofolate reductase mutation in cerebral venous thrombosis. Stroke 2004; 35:1790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/32\">",
"      Laugesaar R, Kahre T, Kolk A, et al. Factor V Leiden and prothrombin 20210G&gt;A [corrected] mutation and paediatric ischaemic stroke: a case-control study and two meta-analyses. Acta Paediatr 2010; 99:1168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/33\">",
"      Gouveia LO, Canh&atilde;o P. MTHFR and the risk for cerebral venous thrombosis--a meta-analysis. Thromb Res 2010; 125:e153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/34\">",
"      de Bruijn SF, Stam J, Koopman MM, Vandenbroucke JP. Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in [correction of who are] carriers of hereditary prothrombotic conditions. The Cerebral Venous Sinus Thrombosis Study Group. BMJ 1998; 316:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/35\">",
"      Bousser MG, Chiras J, Bories J, Castaigne P. Cerebral venous thrombosis--a review of 38 cases. Stroke 1985; 16:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/36\">",
"      Ferro JM, Falcao F, Melo TP, Campos JG. Dural sinus thrombosis mimicking \"capsular warning syndrome\". J Neurol 2000; 247:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/37\">",
"      Biousse V, Ameri A, Bousser MG. Isolated intracranial hypertension as the only sign of cerebral venous thrombosis. Neurology 1999; 53:1537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/38\">",
"      Cumurciuc R, Crassard I, Sarov M, et al. Headache as the only neurological sign of cerebral venous thrombosis: a series of 17 cases. J Neurol Neurosurg Psychiatry 2005; 76:1084.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/39\">",
"      Agostoni E. Headache in cerebral venous thrombosis. Neurol Sci 2004; 25 Suppl 3:S206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/40\">",
"      Ameri A, Bousser MG. Headache in cerebral venous thrombosis: A study of 110 cases. Cephalalgia 1993; 13 (Suppl 13):110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/41\">",
"      Lopes MG, Ferro J, Pontes C, et al for the Venoport Investigators. Headache and cerebral venous thrombosis. Cephalalgia 2000; 20:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/42\">",
"      de Bruijn SF, Stam J, Kappelle LJ. Thunderclap headache as first symptom of cerebral venous sinus thrombosis. CVST Study Group. Lancet 1996; 348:1623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/43\">",
"      Heckmann JG, Sch&uuml;ttler M, Tomandl B. Achard-L&eacute;vi syndrome: pupil-sparing oculomotor nerve palsy due to midbrain stroke. Cerebrovasc Dis 2003; 16:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/44\">",
"      Newman DS, Levine SR, Curtis VL, Welch KM. Migraine-like visual phenomena associated with cerebral venous thrombosis. Headache 1989; 29:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/45\">",
"      Martins IP, S&aacute; J, Pereira RC, et al. Cerebral venous thrombosis &ndash; May mimic migraine with aura. Headache Q 2001; 12:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/46\">",
"      Slooter AJ, Ramos LM, Kappelle LJ. Migraine-like headache as the presenting symptom of cerebral venous sinus thrombosis. J Neurol 2002; 249:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/47\">",
"      Ferro JM, Canh&atilde;o P, Bousser MG, et al. Early seizures in cerebral vein and dural sinus thrombosis: risk factors and role of antiepileptics. Stroke 2008; 39:1152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/48\">",
"      Wasay M, Dai AI, Ansari M, et al. Cerebral venous sinus thrombosis in children: a multicenter cohort from the United States. J Child Neurol 2008; 23:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/49\">",
"      Ferro JM, Canh&atilde;o P, Stam J, et al. Delay in the diagnosis of cerebral vein and dural sinus thrombosis: influence on outcome. Stroke 2009; 40:3133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/50\">",
"      Jacobs K, Moulin T, Bogousslavsky J, et al. The stroke syndrome of cortical vein thrombosis. Neurology 1996; 47:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/51\">",
"      Ahn TB, Roh JK. A case of cortical vein thrombosis with the cord sign. Arch Neurol 2003; 60:1314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/52\">",
"      Cakmak S, Hermier M, Montavont A, et al. T2*-weighted MRI in cortical venous thrombosis. Neurology 2004; 63:1698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/53\">",
"      Damak M, Crassard I, Wolff V, Bousser MG. Isolated lateral sinus thrombosis: a series of 62 patients. Stroke 2009; 40:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/54\">",
"      Utz N, Mull M, Kosinski C, Thron A. Pulsatile tinnitus of venous origin as a symptom of dural sinus thrombosis. Cerebrovasc Dis 1997; 7:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/55\">",
"      Waldvogel D, Mattle HP, Sturzenegger M, Schroth G. Pulsatile tinnitus--a review of 84 patients. J Neurol 1998; 245:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/56\">",
"      Kuehnen J, Schwartz A, Neff W, Hennerici M. Cranial nerve syndrome in thrombosis of the transverse/sigmoid sinuses. Brain 1998; 121 ( Pt 2):381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/57\">",
"      Crawford SC, Digre KB, Palmer CA, et al. Thrombosis of the deep venous drainage of the brain in adults. Analysis of seven cases with review of the literature. Arch Neurol 1995; 52:1101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/58\">",
"      Lafitte F, Boukobza M, Guichard JP, et al. Deep cerebral venous thrombosis: imaging in eight cases. Neuroradiology 1999; 41:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/59\">",
"      Lacour JC, Ducrocq X, Anxionnat R, et al. [Thrombosis of deep cerebral veins in form adults: clinical features and diagnostic approach]. Rev Neurol (Paris) 2000; 156:851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/60\">",
"      van den Bergh WM, van der Schaaf I, van Gijn J. The spectrum of presentations of venous infarction caused by deep cerebral vein thrombosis. Neurology 2005; 65:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/61\">",
"      Wasay M, Bakshi R, Bobustuc G, et al. Cerebral venous thrombosis: analysis of a multicenter cohort from the United States. J Stroke Cerebrovasc Dis 2008; 17:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/62\">",
"      Girot M, Ferro JM, Canh&atilde;o P, et al. Predictors of outcome in patients with cerebral venous thrombosis and intracerebral hemorrhage. Stroke 2007; 38:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/63\">",
"      Dormont D, Anxionnat R, Evrard S, et al. MRI in cerebral venous thrombosis. J Neuroradiol 1994; 21:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/64\">",
"      Lafitte F, Boukobza M, Guichard JP, et al. MRI and MRA for diagnosis and follow-up of cerebral venous thrombosis (CVT). Clin Radiol 1997; 52:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/65\">",
"      Selim M, Fink J, Linfante I, et al. Diagnosis of cerebral venous thrombosis with echo-planar T2*-weighted magnetic resonance imaging. Arch Neurol 2002; 59:1021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/66\">",
"      Leach JL, Fortuna RB, Jones BV, Gaskill-Shipley MF. Imaging of cerebral venous thrombosis: current techniques, spectrum of findings, and diagnostic pitfalls. Radiographics 2006; 26 Suppl 1:S19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/67\">",
"      Meckel S, Reisinger C, Bremerich J, et al. Cerebral venous thrombosis: diagnostic accuracy of combined, dynamic and static, contrast-enhanced 4D MR venography. AJNR Am J Neuroradiol 2010; 31:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/68\">",
"      Rizzo L, Crasto SG, Rud&agrave; R, et al. Cerebral venous thrombosis: role of CT, MRI and MRA in the emergency setting. Radiol Med 2010; 115:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/69\">",
"      Isensee C, Reul J, Thron A. Magnetic resonance imaging of thrombosed dural sinuses. Stroke 1994; 25:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/70\">",
"      Fellner FA, Fellner C, Aichner FT, M&ouml;lzer G. Importance of T2*-weighted gradient-echo MRI for diagnosis of cortical vein thrombosis. Eur J Radiol 2005; 56:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/71\">",
"      Favrole P, Guichard JP, Crassard I, et al. Diffusion-weighted imaging of intravascular clots in cerebral venous thrombosis. Stroke 2004; 35:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/72\">",
"      Virapongse C, Cazenave C, Quisling R, et al. The empty delta sign: frequency and significance in 76 cases of dural sinus thrombosis. Radiology 1987; 162:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/73\">",
"      Lee EJ. The empty delta sign. Radiology 2002; 224:788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/74\">",
"      Boukobza M, Crassard I, Bousser MG. When the \"dense triangle\" in dural sinus thrombosis is round. Neurology 2007; 69:808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/75\">",
"      Sztajzel R, Coeytaux A, Dehdashti AR, et al. Subarachnoid hemorrhage: a rare presentation of cerebral venous thrombosis. Headache 2001; 41:889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/76\">",
"      Oppenheim C, Domigo V, Gauvrit JY, et al. Subarachnoid hemorrhage as the initial presentation of dural sinus thrombosis. AJNR Am J Neuroradiol 2005; 26:614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/77\">",
"      Spitzer C, Mull M, Rohde V, Kosinski CM. Non-traumatic cortical subarachnoid haemorrhage: diagnostic work-up and aetiological background. Neuroradiology 2005; 47:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/78\">",
"      Linn J, Ertl-Wagner B, Seelos KC, et al. Diagnostic value of multidetector-row CT angiography in the evaluation of thrombosis of the cerebral venous sinuses. AJNR Am J Neuroradiol 2007; 28:946.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/79\">",
"      Rodallec MH, Krainik A, Feydy A, et al. Cerebral venous thrombosis and multidetector CT angiography: tips and tricks. Radiographics 2006; 26 Suppl 1:S5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/80\">",
"      Ayanzen RH, Bird CR, Keller PJ, et al. Cerebral MR venography: normal anatomy and potential diagnostic pitfalls. AJNR Am J Neuroradiol 2000; 21:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/81\">",
"      Zouaoui A, Hidden G. Cerebral venous sinuses: anatomical variants or thrombosis? Acta Anat (Basel) 1988; 133:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/82\">",
"      Ferro JM, Morgado C, Sousa R, Canh&atilde;o P. Interobserver agreement in the magnetic resonance location of cerebral vein and dural sinus thrombosis. Eur J Neurol 2007; 14:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/83\">",
"      Casey SO, Alberico RA, Patel M, et al. Cerebral CT venography. Radiology 1996; 198:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/84\">",
"      Majoie CB, van Straten M, Venema HW, den Heeten GJ. Multisection CT venography of the dural sinuses and cerebral veins by using matched mask bone elimination. AJNR Am J Neuroradiol 2004; 25:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/85\">",
"      Wetzel SG, Kirsch E, Stock KW, et al. Cerebral veins: comparative study of CT venography with intraarterial digital subtraction angiography. AJNR Am J Neuroradiol 1999; 20:249.",
"     </a>",
"    </li>",
"    <li>",
"     de Bruijn SF, Majoie CB, Koster PA, et al. Interobserver agreement for MR-imaging and conventional angiography in the diagnosis of cerebral venous thrombosis. In: erebral venous sinus thrombosis. Clinical and epidemiological studies, de Bruijn SF (Ed), Thesis, Amsterdam 1998. p.23.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/87\">",
"      Canh&atilde;o P, Batista P, Ferro JM. Venous transcranial Doppler in acute dural sinus thrombosis. J Neurol 1998; 245:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/88\">",
"      Valdueza JM, Hoffmann O, Weih M, et al. Monitoring of venous hemodynamics in patients with cerebral venous thrombosis by transcranial Doppler ultrasound. Arch Neurol 1999; 56:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/89\">",
"      Becker G, Bogdahn U, Gehlberg C, et al. Transcranial color-coded real-time sonography of intracranial veins. Normal values of blood flow velocities and findings in superior sagittal sinus thrombosis. J Neuroimaging 1995; 5:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/90\">",
"      Ries S, Steinke W, Neff KW, Hennerici M. Echocontrast-enhanced transcranial color-coded sonography for the diagnosis of transverse sinus venous thrombosis. Stroke 1997; 28:696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/91\">",
"      Stolz E, Kaps M, Dorndorf W. Assessment of intracranial venous hemodynamics in normal individuals and patients with cerebral venous thrombosis. Stroke 1999; 30:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/92\">",
"      Tardy B, Tardy-Poncet B, Viallon A, et al. D-dimer levels in patients with suspected acute cerebral venous thrombosis. Am J Med 2002; 113:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/93\">",
"      Lalive PH, de Moerloose P, Lovblad K, et al. Is measurement of D-dimer useful in the diagnosis of cerebral venous thrombosis? Neurology 2003; 61:1057.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/94\">",
"      Kosinski CM, Mull M, Schwarz M, et al. Do normal D-dimer levels reliably exclude cerebral sinus thrombosis? Stroke 2004; 35:2820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/26/7594/abstract/95\">",
"      Crassard I, Soria C, Tzourio C, et al. A negative D-dimer assay does not rule out cerebral venous thrombosis: a series of seventy-three patients. Stroke 2005; 36:1716.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1103 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-180.241.123.62-8D972B75FE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_26_7594=[""].join("\n");
var outline_f7_26_7594=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL ASPECTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Symptoms and signs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Headache",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Encephalopathy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Focal symptoms and signs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Seizures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Variables affecting presentation and course",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Isolated sinus and vein thrombosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Neuroimaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - MRI",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H174063473\">",
"      - MR venography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Head CT",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6837204\">",
"      - CT venography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Laboratory tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Evaluation for the cause of CVT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/1103\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/1103|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?40/3/41022\" title=\"algorithm 1\">",
"      Mechanisms of CVT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/1103|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?22/13/22740\" title=\"diagnostic image 1\">",
"      SSS thrombosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?6/6/6243\" title=\"diagnostic image 2\">",
"      Parenchymal brain lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?36/38/37473\" title=\"diagnostic image 3\">",
"      Hemorrhagic venous infarct",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?13/14/13537\" title=\"diagnostic image 4\">",
"      CT scan signs of CVT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/1103|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/9/17557\" title=\"figure 1\">",
"      Cerebral veins and sinuses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/1103|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/31/3581\" title=\"table 1\">",
"      Risk factors for CVT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?4/21/4443\" title=\"table 2\">",
"      Prothrombotic risk factors",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/36/24136?source=related_link\">",
"      Antithrombin (ATIII) deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/29/27096?source=related_link\">",
"      Diagnosis of the antiphospholipid syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38522?source=related_link\">",
"      Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/53/30552?source=related_link\">",
"      Overview and differential diagnosis of papilledema",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43786?source=related_link\">",
"      Overview of the causes of venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/25/8600?source=related_link\">",
"      Pathophysiology, clinical features, and diagnosis of migraine in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/4/26698?source=related_link\">",
"      Pathophysiology, clinical manifestations, and diagnosis of migraine in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/46/20198?source=related_link\">",
"      Post-lumbar puncture headache",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/52/841?source=related_link\">",
"      Protein C deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/55/13176?source=related_link\">",
"      Protein S deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/2/27690?source=related_link\">",
"      Stroke in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/19/12601?source=related_link\">",
"      Thunderclap headache",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/16/9482?source=related_link\">",
"      Treatment and prognosis of cerebral venous thrombosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_26_7595="Vulvodynia history";
var content_f7_26_7595=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F72042&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=10\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F72042&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=10\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Elements of the history in women with vulvodynia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Presence of vulvar lesions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Medical history",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pelvic or vulvovaginal surgery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pregnancy history",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Injury to or dislocation of hips",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sports injuries",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Back injuries or surgery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Herniated disk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Arthritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Spinal stenosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Occupation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Leisure activities",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_26_7595=[""].join("\n");
var outline_f7_26_7595=null;
var title_f7_26_7596="Drug-induced linear IgA bullous dermatosis";
var content_f7_26_7596=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F83569&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F83569&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Drug-induced linear IgA bullous dermatosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Common",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vancomycin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Less common",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Penicillins",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cephalosporins",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Captopril &gt;other ACE inhibitors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        NSAIDs: diclofenac, naproxen, oxaprozin, piroxicam",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Uncommon",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Phenytoin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sulfonamide antibiotics: sulfamethoxazole, sulfisoxazole",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Rare",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Amiodarone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Angiotensin receptor blockers: candesartan, eprosartan",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Atorvastatin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carbamazepine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cyclosporine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Furosemide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gemcitabine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Glyburide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Granulocyte colony-stimulating factor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Interferon-&alpha; and interferon-&gamma;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Interleukin-2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lithium carbonate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        PUVA",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rifampin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Somatostatin",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <p>",
"     &nbsp;",
"    </p>",
"    <div class=\"footnotes\">",
"     ACE: angiotensin converting enzyme; NSAIDs: nonsteroidal antiinflammatory drugs.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Zone JJ. Dermatitis herpetiformis and linear IgA bullous dermatosis. In: Dermatology, 2nd ed, Bolognia JL, Jorizzo JL, Rapini RP (Eds), Elsevier, 2008. Table used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_26_7596=[""].join("\n");
var outline_f7_26_7596=null;
var title_f7_26_7597="Differential dx food reactions";
var content_f7_26_7597=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F51225&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F51225&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Nonimmunologic adverse food reactions",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Gastrointestinal disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Structural abnormalities",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hiatal hernia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Pyloric stenosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Tracheoesophageal fistula",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hirschsprung's disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Carbohydrate malabsorption",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Lactase deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Sucrose-isomaltase deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pancreatic insufficiency (cystic fibrosis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gastroesophageal reflux",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Peptic ulcer disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gallbladder disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Toxic reactions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Seafood",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Scromboid poisoning (fresh tuna and mackerel)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Ciguatera poisoning (grouper, snapper)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Saxitoxin (shellfish)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Other food poisoning",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Clostridium botulinum",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Staphylococcus aureus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fungal toxins (aflatoxins, trichothecanes, ergot)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Intolerances",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Pharmacologic agents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Caffeine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Theobromine (tea, chocolate)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Histamine-like compounds (fish, wine, sauerkraut)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Tryptamine (tomato, plum)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Tyramine (aged cheeses, pickled fish)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Serotonin (banana, tomato)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Phenylethylamine (chocolate)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Glycosidal alkaloid solanine (potatoes)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Alcohol",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Flavorings and preservatives",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Sodium metabisulfite",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Monosodium glutamate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Neurologic reactions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Auriculotemporal syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Psychologic reactions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Food phobias",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Food aversions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Accidental contaminations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pesticides",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Antibiotics (if allergy present)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from: Sampson HA. Differential Diagnosis in adverse reactions to foods. J Allergy Clin Immunol 1986; 78:212. Copyright &copy; 1086 Elsevier Science, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_26_7597=[""].join("\n");
var outline_f7_26_7597=null;
var title_f7_26_7598="PSE after TIPS";
var content_f7_26_7598=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F72160&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F72160&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Portosystemic encephalopathy after TIPS",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 421px; height: 276px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Changes in the portosystemic encephalopathy (PSE) index in patients treated with endoscopic sclerotherapy (EST, left) or insertion of a transjugular intrahepatic stent shunt (TIPS, right). There were no significant changes in the PSE index with EST, whereas there was a significant worsening in patients treated with TIPS. The effect was most pronounced at one month; the values returned toward baseline at six months but were still significantly higher than in the EST arm.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Sanyal, AJ, Freedman, AM, Shiffman, ML, et al, Hepatology 1994; 20:46.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_26_7598=[""].join("\n");
var outline_f7_26_7598=null;
var title_f7_26_7599="Pathogenesis of PBC";
var content_f7_26_7599=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F73762&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F73762&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pathogenesis of primary biliary cirrhosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 530px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The initial requirement is a genetically susceptible host, which may involve an inability to suppress an immunologically mediated attack on bile duct cells once it has begun. Some triggering event is required to set this process in motion; it could be any event that damages bile duct cells and exposes the unique PBC bile duct cell antigen to the cellular or humoral immune system. Progressive damage to bile duct cells causes cholestasis. This sets up a vicious cycle in which retention of toxic substances, such as bile acids, cause chemical damage to hepatocytes. Cholestasis also causes increased expression of HLA Class I and II antigens on bile duct cells and hepatocytes which make them better targets for activated lymphocytes. The gradual loss of bile ducts causes progressive scarring, cirrhosis, portal hypertension and eventually, liver failure.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_26_7599=[""].join("\n");
var outline_f7_26_7599=null;
